EXFO
ELECTRO-OPTICAL ENGINEERING INC.
|
|
By:
/s/ Germain
Lamonde
Name:
Germain Lamonde
Title:
President and Chief Executive
Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated
Statements of Earnings Data
|
2006
|
|
2005
|
|
2004
|
|
2003
|
|
2002
|
|||||||
Sales
|
$
|
128,253
|
$
|
97,216
|
$
|
74,630
|
$
|
61,930
|
$
|
68,330
|
||||||
Gross
margin (1)
|
$
|
70,978
|
$
|
53,157
|
$
|
40,074
|
$
|
25,733
|
$
|
15,964
|
||||||
55.3
|
%
|
54.7
|
%
|
53.7
|
%
|
41.6
|
%
|
23.4
|
%
|
|||||||
Selling
and administrative
|
$
|
40,298
|
$
|
31,782
|
$
|
25,890
|
$
|
26,991
|
$
|
33,881
|
||||||
31.4
|
%
|
32.7
|
%
|
34.7
|
%
|
43.6
|
%
|
49.6
|
%
|
|||||||
Net
research and development
|
$
|
15,404
|
$
|
12,190
|
$
|
12,390
|
$
|
15,879
|
$
|
12,782
|
||||||
12.0
|
%
|
12.5
|
%
|
16.6
|
%
|
25.6
|
%
|
18.7
|
%
|
|||||||
Earnings
(loss) from operations (2)
|
$
|
8,062
|
$
|
(199
|
)
|
$
|
(10,570
|
)
|
$
|
(39,584
|
)
|
$
|
(74,783
|
)
|
||
6.3
|
%
|
(0.2
|
%)
|
(14.1
|
%)
|
(63.9
|
%)
|
(109.4
|
%)
|
|||||||
Net
earnings (loss)
|
$
|
8,135
|
$
|
(1,634
|
)
|
$
|
(8,424
|
)
|
$
|
(54,950
|
)
|
$
|
(308,524
|
)
|
||
6.3
|
%
|
(1.7
|
%)
|
(11.3
|
%)
|
(88.7
|
%)
|
(451.5
|
%)
|
|||||||
Basic
and diluted net earnings (loss) per share
|
$
|
0.12
|
$
|
(0.02
|
)
|
$
|
(0.13
|
)
|
$
|
(0.87
|
)
|
$
|
(5.09
|
)
|
||
Consolidated
Balance Sheets Data
|
||||||||||||||||
Cash
and short-term investments
|
$
|
111,290
|
$
|
112,002
|
$
|
89,128
|
$
|
57,376
|
$
|
49,681
|
||||||
Working
capital
|
$
|
143,985
|
$
|
135,288
|
$
|
115,141
|
$
|
77,408
|
$
|
91,374
|
||||||
Total
assets
|
$
|
219,159
|
$
|
190,957
|
$
|
172,791
|
$
|
146,254
|
$
|
177,926
|
||||||
Long-term
debt (excluding current portion)
|
$
|
354
|
$
|
198
|
$
|
332
|
$
|
453
|
$
|
564
|
||||||
Shareholders’
equity
|
$
|
196,234
|
$
|
173,400
|
$
|
157,327
|
$
|
129,826
|
$
|
165,406
|
(1)
|
Including
inventory write-offs of $4,121,000 and $18,463,000 for the years
ended
August 31, 2003 and 2002, respectively, and nil for the years ended
August
31, 2006, 2005 and 2004. Including an unusual gain of $473,000
for the
year ended August 31, 2003, and nil for the years ended August
31, 2006,
2005, 2004 and 2002.
|
(2)
|
Including
stock-based compensation costs, inventory and tax credit write-offs,
unusual grants recovery, amortization of intangible assets, impairment
of
long-lived assets and goodwill as well as restructuring and other
charges
of $4,723,000, $6,091,000, $7,878,000, $22,943,000 and $57,451,000
for the
years ended August 31, 2006, 2005, 2004, 2003 and 2002,
respectively.
|
-
|
Increased
sales 31.9% to $128.3 million in 2006 mainly through organic
growth;
|
-
|
Delivered
sales growth of 34.0% and 22.1% year-over-year for our Telecom
Division
and Life Sciences & Industrial Division,
respectively;
|
-
|
Posted
sales CAGRs of 27.5% and 20.9% over the last three and ten years,
respectively, despite a major telecom crisis in
2001;
|
-
|
Achieved
GAAP net earnings of $8.1 million and GAAP operating margin of
6.3%;
|
-
|
Generated
$0.31 in earnings before income taxes for every additional dollar
of
revenue in 2006 over 2005;
|
-
|
Produced
$12.3 million in cash flows from operating
activities;
|
-
|
Derived
37.1% of sales from new products on the market two years or
less;
|
-
|
Acquired
Consultronics for $19.1 million in cash, strategically positioning
EXFO
for the triple-play, broadband access test
market;
|
-
|
Consolidated
leadership position in the portable optical test market with a
third
consecutive Growth Strategy Leadership Award from Frost & Sullivan for
achieving highest organic market-share
gains;
|
-
|
Posted
best sales and bookings year in company history for protocol business,
which is growing much faster than our Telecom Division;
and
|
-
|
Received
Product Differentiation Innovation Award from Frost & Sullivan for new
portfolio of protocol test solutions dedicated to next-generation
and
traditional SONET/SDH networks.
|
-
|
Market-driven
innovation.
We are first and foremost a market-driven company, highly focused
on
anticipating market trends and developing value-added solutions
that go
beyond satisfying our customers’ requirements. Our aim is to deliver
targeted products with just the right features to customers on
a global
basis.
|
-
|
Outstanding
execution. Market-driven
innovation provides us with superior products and early market
advantages
over competitors. But paying meticulous attention to all aspects
of the
customer experience, combined with outstanding product quality
and
proficient technical expertise, enables us to expand our customer
base and
convert these short-term advantages into long-term market-share
gains.
|
-
|
Unique
modular platform design. A
decade ago, we were the first in our industry to introduce PC-based,
Windows-driven modular test platforms — sharing a common series of test
modules — for different end-markets. We have continued to build on our
first-mover advantage with the launch of next-generation platforms
and
additional best-in-class test modules in order to expand our technology
base. This unique platform strategy provides our customers with
costefficient and scalable test solutions, while allowing us to
leverage
R&D investments across multiple
end-markets.
|
-
|
Quality
people. Around
the world, we have a long list of employees who share a common
passion for
excellence and a real dedication to serve our customers. These
people,
prominent within all levels of our organization, always place customers
first and spare no efforts to succeed as finishing second is not
an option
for them. I refer to these people as “EXFO bluebloods.” Their hard work,
enthusiasm and commitment are among the main reasons why EXFO is
a winner
in my book.
|
Goal
|
Metric
|
Result
|
Increase
sales through market-share gains
|
25%
sales growth year-over-year*
|
31.9%
sales growth year-over-year
|
Maximize
profitability
|
GAAP
operating margin of 5%
|
GAAP
operating margin of 6.3%
|
Focus
on innovation
|
40%
of sales from new products
|
37.1%
of sales from new products
|
*
Sales growth metric was updated at the end of the second quarter
in 2006
to reflect mid-year results and Consultronics
acquisition.
|
-
|
Our
OmniCure product line, focused on UV spot-curing applications,
has enjoyed
significant growth within the medical and optoelectronics industries.
These diverse markets, largely influenced by the miniaturization
trend,
are expanding worldwide with Asia showing the largest year-over-year
growth.
|
-
|
Our
X-Cite series, an add-on illumination system for high-end microscopes,
has
entrenched itself as a market leader in various research areas.
The global
fluorescence microscopy market is growing in mid-single digits,
while live
cell and quantitative imaging are increasingly gaining
traction.
|
-
|
Our
Burleigh nanopositioning product line, mainly designed for cellular
micromanipulation, continues to demonstrate strong brandname recognition
and loyal following with electrophysiologists. It targets a stable
growth
market focused on fundamental neuroscience and drug
discovery.
|
-
|
Grow
revenues by at least 20%
year-over-year;
|
-
|
Generate
a GAAP operating margin of more than 7%;
and
|
-
|
Derive
at least 35% of sales from new products (on the market two years
or
less).
|
-
|
Posts
sales growth of 31.9%
year-over-year
|
-
|
Completes
fiscal 2006 with a total of 18 new
products
|
-
|
Adds
optical transport network (OTN) testing to protocol
portfolio
|
-
|
Receives
Growth Strategy Leadership Award from Frost & Sullivan forthird
consecutive year
|
-
|
Releases
VoIP/DSL test set
|
-
|
Introduces
CoLT-450P, an enhanced solution for IPTV-over-DSL and triple-play
testing
|
-
|
Launches
compact Ethernet test solution
|
-
|
Releases
X-Cite®120
XL Fluorescence Illumination System
|
-
|
Launches
new EPON/GPON power meter for service-activation testing and
troubleshooting of FTTx networks
|
-
|
Introduces
SONET/SDH test modules for FTB-200 Compact
Platform
|
-
|
Launches
next-generation SONET/SDH test modules for FTB-400 Universal Test
System
|
-
|
Releases
next-generation SONET/SDH test modules for IQS-500 Intelligent
Test
System
|
-
|
Acquires
assets of Consultronics
|
-
|
Introduces
FTB-200 Compact Platform for multi-layer, multi-medium
testing
|
-
|
Launches
AXS-100 OTDR for FTTx test
applications
|
-
|
Receives
sole-source approval for all fiber deployment applications by Deutsche
Telekom
|
-
|
Releases
protocol analysis software for field-test applications on Ethernet
networks
|
-
|
Launches
10 Gigabit Ethernet test solution for manufacturing and lab
environments
|
-
|
Releases
next-generation Fibre Channel test solution for manufacturing and
lab
environments
|
Strategic
objectives for for fiscal 2007
|
Key
performance indicators fiscal 2007
|
Increase
sales through market-share gains
|
20%
sales growth year-over-year
|
Maximize
profitability
|
7%
in earnings from operations
|
Focus
on innovation
|
35%
of sales from new products
|
(on
the market two years or less)
|
Consolidated
statements of earnings data:
|
2006
|
|
2005
|
|
2004
|
|
2006
|
|
2005
|
|
2004
|
||||||||
Sales
|
$
|
128,253
|
$
|
97,216
|
$
|
74,630
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
|||||||
Cost
of sales (1)
|
57,275
|
44,059
|
34,556
|
44.7
|
45.3
|
46.3
|
|||||||||||||
Gross
margin
|
70,978
|
53,157
|
40,074
|
55.3
|
54.7
|
53.7
|
|||||||||||||
Operating
expenses
|
|||||||||||||||||||
Selling
and administrative
|
40,298
|
31,782
|
25,890
|
31.4
|
32.7
|
34.7
|
|||||||||||||
Net
research and development
|
15,404
|
12,190
|
12,390
|
12.0
|
12.5
|
16.6
|
|||||||||||||
Amortization
of property, plant and equipment
|
3,523
|
4,256
|
4,935
|
2.7
|
4.4
|
6.6
|
|||||||||||||
Amortization
of intangible assets
|
4,394
|
4,836
|
5,080
|
3.4
|
5.0
|
6.8
|
|||||||||||||
Impairment
of long-lived assets
|
604
|
−
|
620
|
0.5
|
−
|
0.8
|
|||||||||||||
Government
grants
|
(1,307
|
)
|
−
|
−
|
(1.0
|
)
|
−
|
−
|
|||||||||||
Restructuring
and other charges
|
−
|
292
|
1,729
|
−
|
0.3
|
2.3
|
|||||||||||||
Total
operating expenses
|
62,916
|
53,356
|
50,644
|
49.0
|
54.9
|
67.8
|
|||||||||||||
Earnings
(loss) from operations
|
8,062
|
(199
|
)
|
(10,570
|
)
|
6.3
|
(0.2
|
)
|
(14.1
|
)
|
|||||||||
Interest
and other income
|
3,253
|
2,524
|
1,438
|
2.5
|
2.6
|
1.9
|
|||||||||||||
Foreign
exchange loss
|
(595
|
)
|
(1,336
|
)
|
(278
|
)
|
(0.5
|
)
|
(1.4
|
)
|
(0.4
|
)
|
|||||||
Earnings
(loss) before income taxes
|
10,720
|
989
|
(9,410
|
)
|
8.3
|
1.0
|
(12.6
|
)
|
|||||||||||
Income
taxes
|
2,585
|
2,623
|
(986
|
)
|
2.0
|
2.7
|
(1.3
|
)
|
|||||||||||
Net
earnings (loss) for the year
|
$
|
8,135
|
$
|
(1,634
|
)
|
$
|
(8,424
|
)
|
6.3
|
%
|
(1.7
|
)%
|
(11.3
|
)%
|
|||||
Basic
and diluted net earnings (loss) per share
|
$
|
0.12
|
$
|
(0.02
|
)
|
$
|
(0.13
|
)
|
|||||||||||
Segment
information
|
|||||||||||||||||||
Sales:
|
|||||||||||||||||||
Telecom
Division
|
$
|
107,376
|
$
|
80,120
|
$
|
58,882
|
83.7
|
%
|
82.4
|
%
|
78.9
|
%
|
|||||||
Life
Sciences and Industrial Division
|
20,877
|
17,096
|
15,748
|
16.3
|
17.6
|
21.1
|
|||||||||||||
$
|
128,253
|
$
|
97,216
|
$
|
74,630
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
||||||||
Operating
earnings (loss):
|
|||||||||||||||||||
Telecom
Division
|
$
|
6,679
|
$
|
763
|
$
|
(5,557
|
)
|
5.2
|
%
|
0.8
|
%
|
(7.4
|
)%
|
||||||
Life
Sciences and Industrial Division
|
1,383
|
(962
|
)
|
(5,013
|
)
|
1.1
|
(1.0
|
)
|
(6.7
|
)
|
|||||||||
$
|
8,062
|
$
|
(199
|
)
|
$
|
(10,570
|
)
|
6.3
|
%
|
(0.2
|
)%
|
(14.1
|
)%
|
||||||
Research
and development data:
|
|||||||||||||||||||
Gross
research and development
|
$
|
19,488
|
$
|
15,878
|
$
|
15,668
|
15.2
|
%
|
16.3
|
%
|
21.0
|
%
|
|||||||
Net
research and development
|
$
|
15,404
|
$
|
12,190
|
$
|
12,390
|
12.0
|
%
|
12.5
|
%
|
16.6
|
%
|
|||||||
Consolidated
balance sheets data:
|
|||||||||||||||||||
Total
assets
|
$
|
219,159
|
$
|
190,957
|
$
|
172,791
|
(1)
|
The
cost of sales is exclusive of amortization, shown
separately.
|
Years
ending August 31,
|
2007
|
2008
|
2009
|
2010
|
2011
and later
|
Total
|
|||||||||||||
Long-term
debt
|
$
|
107,000
|
$
|
113,000
|
$
|
118,000
|
$
|
123,000
|
$
|
−
|
$
|
461,000
|
|||||||
Operating
leases
|
1,748,000
|
1,223,000
|
1,177,000
|
1,200,000
|
1,540,000
|
6,888,000
|
|||||||||||||
Total
commitments
|
$
|
1,855,000
|
$
|
1,336,000
|
$
|
1,295,000
|
$
|
1,323,000
|
$
|
1,540,000
|
$
|
7,349,000
|
Expiry
dates
|
Contractual
amounts
|
Weighted
average
contractual
forward
rates
|
|||||
September
2006 to August 2007
|
$
|
37,000,000
|
1.1676
|
||||
September
2007 to June 2009
|
26,800,000
|
1.1261
|
Stock
Options
|
Number
|
%
of issued and outstanding
|
Weighted
average exercise price
|
|||||||
Chairman
of the Board, President and CEO (one individual)
|
179,642
|
7
|
%
|
$
|
9.05
|
|||||
Board
of Directors (five individuals)
|
194,375
|
8
|
%
|
$
|
6.23
|
|||||
Management
and Corporate Officers (eight individuals)
|
313,836
|
13
|
%
|
$
|
15.42
|
|||||
687,853
|
28
|
%
|
$
|
11.16
|
Restricted
Share Units (RSUs)
|
Number
|
%
of issued and outstanding
|
|||||
Chairman
of the Board, President and CEO (one individual)
|
59,913
|
14
|
%
|
||||
Management
and Corporate Officers (ten individuals)
|
255,616
|
60
|
%
|
||||
315,529
|
74
|
%
|
Deferred
Share Units (DSUs)
|
Number
|
%
of issued and outstanding
|
|||||
Board
of Directors (five individuals)
|
43,290
|
100
|
%
|
1st
quarter
|
2nd
quarter
|
3rd
quarter
|
4th
quarter
|
Years
ended August 31,
|
||||||||||||
2006
|
||||||||||||||||
Sales
|
$
|
27,044
|
$
|
30,066
|
$
|
35,410
|
$
|
35,733
|
$
|
128,253
|
||||||
Cost
of sales
|
$
|
12,064
|
$
|
13,440
|
$
|
15,453
|
$
|
16,318
|
$
|
57,275
|
||||||
Gross
margin
|
$
|
14,980
|
$
|
16,626
|
$
|
19,957
|
$
|
19,415
|
$
|
70,978
|
||||||
Earnings
from operations
|
$
|
683
|
$
|
1,408
|
$
|
3,608
|
$
|
2,363
|
$
|
8,062
|
||||||
Net
earnings
|
$
|
355
|
$
|
1,366
|
$
|
3,504
|
$
|
2,910
|
$
|
8,135
|
||||||
Basic
and diluted net earnings per share
|
$
|
0.01
|
$
|
0.02
|
$
|
0.05
|
$
|
0.04
|
$
|
0.12
|
||||||
2005
|
||||||||||||||||
Sales
|
$
|
21,597
|
$
|
23,135
|
$
|
26,180
|
$
|
26,304
|
$
|
97,216
|
||||||
Cost
of sales
|
$
|
10,225
|
$
|
10,431
|
$
|
11,478
|
$
|
11,925
|
$
|
44,059
|
||||||
Gross
margin
|
$
|
11,372
|
$
|
12,704
|
$
|
14,702
|
$
|
14,379
|
$
|
53,157
|
||||||
Earnings
(loss) from operations
|
$
|
(1,337
|
)
|
$
|
(182
|
)
|
$
|
509
|
$
|
811
|
$
|
(199
|
)
|
|||
Net
earnings (loss)
|
$
|
(2,373
|
)
|
$
|
9
|
$
|
276
|
$
|
454
|
$
|
(1,634
|
)
|
||||
Basic
and diluted net earnings (loss) per share
|
$
|
(0.03
|
)
|
$
|
—
|
$
|
—
|
$
|
0.01
|
$
|
(0.02
|
)
|
||||
2004
|
||||||||||||||||
Sales
|
$
|
15,962
|
$
|
16,880
|
$
|
20,456
|
$
|
21,332
|
$
|
74,630
|
||||||
Cost
of sales
|
$
|
7,815
|
$
|
7,528
|
$
|
9,637
|
$
|
9,576
|
$
|
34,556
|
||||||
Gross
margin
|
$
|
8,147
|
$
|
9,352
|
$
|
10,819
|
$
|
11,756
|
$
|
40,074
|
||||||
Loss
from operations
|
$
|
(3,145
|
)
|
$
|
(3,485
|
)
|
$
|
(1,888
|
)
|
$
|
(2,052
|
)
|
$
|
(10,570
|
)
|
|
Net
loss
|
$
|
(2,008
|
)
|
$
|
(2,885
|
)
|
$
|
(1,188
|
)
|
$
|
(2,343
|
)
|
$
|
(8,424
|
)
|
|
Basic
and diluted net loss per share (1)
|
$
|
(0.03
|
)
|
$
|
(0.04
|
)
|
$
|
(0.02
|
)
|
$
|
(0.03
|
)
|
$
|
(0.13
|
)
|
(1)
|
Per
share data is calculated independently for each of the quarters
presented.
Therefore, the sum of this quarterly information does not equal
the
corresponding annual information.
|
Germain
Lamonde
|
Pierre
Plamondon, CA
|
|
Chairman,
President and CEO
|
Vice-President,
Finance and Chief Financial
Officer
|
As
at August 31,
|
2006
|
2005
|
|||||
Assets
|
|||||||
Current
assets
|
|||||||
Cash
|
$
|
6,853
|
$
|
7,119
|
|||
Short-term
investments (notes 8 and 18)
|
104,437
|
104,883
|
|||||
Accounts
receivable (notes 8 and 18)
|
|||||||
Trade
|
20,891
|
13,945
|
|||||
Other
(note 4)
|
2,792
|
2,007
|
|||||
Income
taxes and tax credits recoverable (note 8)
|
2,201
|
2,392
|
|||||
Inventories
(notes 5 and 8)
|
24,623
|
17,749
|
|||||
Prepaid
expenses
|
1,404
|
1,112
|
|||||
163,201
|
149,207
|
||||||
Income
taxes recoverable
|
476
|
459
|
|||||
Property,
plant and equipment (notes
4, 6 and 8)
|
17,392
|
13,719
|
|||||
Long-lived
asset held for sale (note
4)
|
—
|
1,600
|
|||||
Intangible
assets (notes
7 and 8)
|
10,948
|
5,602
|
|||||
Goodwill
(note
7)
|
27,142
|
20,370
|
|||||
$
|
219,159
|
$
|
190,957
|
||||
Liabilities
|
|||||||
Current
liabilities
|
|||||||
Accounts
payable and accrued liabilities (note 9)
|
$
|
17,337
|
$
|
12,201
|
|||
Deferred
revenue
|
1,772
|
1,584
|
|||||
Current
portion of long-term debt
|
107
|
134
|
|||||
19,216
|
13,919
|
||||||
Deferred
revenue
|
2,632
|
1,568
|
|||||
Government
grants (note
15)
|
723
|
1,872
|
|||||
Long-term
debt (note
10)
|
354
|
198
|
|||||
22,925
|
17,557
|
||||||
Commitments
(note
11)
|
|||||||
Contingencies
(note
12)
|
|||||||
Shareholders’
Equity
|
|||||||
Share
capital (note 13)
|
148,921
|
521,875
|
|||||
Contributed
surplus
|
3,776
|
2,949
|
|||||
Deficit
(note 13)
|
—
|
(381,846
|
)
|
||||
Cumulative
translation adjustment
|
43,537
|
30,422
|
|||||
196,234
|
173,400
|
||||||
$
|
219,159
|
$
|
190,957
|
On
behalf of the Board
|
Germain
Lamonde
|
André
Tremblay
|
|
Chairman,
President and CEO
|
Chairman,
Audit Committee
|
Years
ended August 31,
|
2006
|
2005
|
2004
|
|||||||
Sales
(note
19)
|
$
|
128,253
|
$
|
97,216
|
$
|
74,630
|
||||
Cost
of sales (1,2)
|
57,275
|
44,059
|
34,556
|
|||||||
Gross
margin
|
70,978
|
53,157
|
40,074
|
|||||||
Operating
expenses
|
||||||||||
Selling
and administrative (1)
|
40,298
|
31,782
|
25,890
|
|||||||
Net
research and development (1)
(note
15)
|
15,404
|
12,190
|
12,390
|
|||||||
Amortization
of property, plant and equipment
|
3,523
|
4,256
|
4,935
|
|||||||
Amortization
of intangible assets
|
4,394
|
4,836
|
5,080
|
|||||||
Impairment
of long-lived assets (note 4)
|
604
|
—
|
620
|
|||||||
Government
grants (note 15)
|
(1,307
|
)
|
—
|
—
|
||||||
Restructuring
and other charges (note 4)
|
—
|
292
|
1,729
|
|||||||
Total
operating expenses
|
62,916
|
53,356
|
50,644
|
|||||||
Earnings
(loss) from operations
|
8,062
|
(199
|
)
|
(10,570
|
)
|
|||||
Interest
and other income
|
3,253
|
2,524
|
1,438
|
|||||||
Foreign
exchange loss
|
(595
|
)
|
(1,336
|
)
|
(278
|
)
|
||||
Earnings
(loss) before income taxes (note
16)
|
10,720
|
989
|
(9,410
|
)
|
||||||
Income
taxes (note
16)
|
2,585
|
2,623
|
(986
|
)
|
||||||
Net
earnings (loss) for the year
|
$
|
8,135
|
$
|
(1,634
|
)
|
$
|
(8,424
|
)
|
||
Basic
and diluted net earnings (loss) per share
|
$
|
0.12
|
$
|
(0.02
|
)
|
$
|
(0.13
|
)
|
||
Basic
weighted average number of shares outstanding
(000’s)
|
68,643
|
68,526
|
66,020
|
|||||||
Diluted
weighted average number of shares outstanding (000’s)
(note
17)
|
69,275
|
68,981
|
66,615
|
|||||||
(1)
Stock-based
compensation costs included in:
|
||||||||||
Cost
of sales
|
$
|
127
|
$
|
143
|
$
|
62
|
||||
Selling
and administrative
|
701
|
626
|
265
|
|||||||
Net
research and development
|
204
|
194
|
122
|
|||||||
$
|
1,032
|
$
|
963
|
$
|
449
|
(2)
|
The
cost of sales is exclusive of amortization, shown
separately.
|
Deficit
|
||||||||||
Years
ended August 31,
|
2006
|
2005
|
2004
|
|||||||
Balance
- Beginning of year
|
$
|
(381,846
|
)
|
$
|
(380,212
|
)
|
$
|
(371,788
|
)
|
|
Deduct
(add)
|
||||||||||
Net
earnings (loss) for the year
|
8,135
|
(1,634
|
)
|
(8,424
|
)
|
|||||
Elimination
of deficit by reduction of share capital (note 13)
|
373,711
|
-
|
-
|
|||||||
Balance
- End of year
|
$
|
-
|
$
|
(381,846
|
)
|
$
|
(380,212
|
)
|
Contributed
surplus
|
||||||||||
Years
ended August 31,
|
2006
|
2005
|
2004
|
|||||||
Balance
- Beginning of year
|
$
|
2,949
|
$
|
1,986
|
$
|
1,519
|
||||
Add
(deduct)
|
||||||||||
Stock-based
compensation costs
|
1,027
|
963
|
449
|
|||||||
Reclassification
of stock-based compensation costs to share capital upon exercise
of stock
awards (note 13)
|
(200
|
)
|
-
|
-
|
||||||
Premium
on resale of share capital
|
-
|
-
|
18
|
|||||||
Balance
- End of year
|
$
|
3,776
|
$
|
2,949
|
$
|
1,986
|
Years
ended August 31,
|
2006
|
|
2005
|
|
2004
|
|||||
Cash
flows from operating activities
|
||||||||||
Net
earnings (loss) for the year
|
$
|
8,135
|
$
|
(1,634
|
)
|
$
|
(8,424
|
)
|
||
Add
(deduct) items not affecting cash
|
||||||||||
Discount
on short-term investments
|
(229
|
)
|
(302
|
)
|
197
|
|||||
Stock-based
compensation costs
|
1,032
|
963
|
449
|
|||||||
Amortization
|
7,917
|
9,092
|
10,015
|
|||||||
Impairment
of long-lived assets
|
604
|
-
|
620
|
|||||||
Restructuring
and other charges
|
-
|
-
|
1,261
|
|||||||
Government
grants
|
(1,307
|
)
|
-
|
154
|
||||||
Deferred
revenue
|
786
|
977
|
1,404
|
|||||||
16,938
|
9,096
|
5,676
|
||||||||
Change
in non-cash operating items
|
||||||||||
Accounts
receivable
|
(2,637
|
)
|
(838
|
)
|
(2,677
|
)
|
||||
Income
taxes and tax credits
|
329
|
6,096
|
(2,464
|
)
|
||||||
Inventories
|
(2,287
|
)
|
(699
|
)
|
1,016
|
|||||
Prepaid
expenses
|
79
|
544
|
(449
|
)
|
||||||
Accounts
payable and accrued liabilities
|
(144
|
)
|
(164
|
)
|
(351
|
)
|
||||
12,278
|
14,035
|
751
|
||||||||
Cash
flows from investing activities
|
||||||||||
Additions
to short-term investments
|
(673,289
|
)
|
(585,665
|
)
|
(653,348
|
)
|
||||
Proceeds
from disposal and maturity of short-term investments
|
681,500
|
574,207
|
624,722
|
|||||||
Additions
to property, plant and equipment and intangible assets
|
(3,378
|
)
|
(1,501
|
)
|
(851
|
)
|
||||
Business
combinations, net of cash acquired
|
(18,054
|
)
|
-
|
(241
|
)
|
|||||
(13,221
|
)
|
(12,959
|
)
|
(29,718
|
)
|
|||||
Cash
flows from financing activities
|
||||||||||
Repayment
of long-term debt
|
(415
|
)
|
(121
|
)
|
(109
|
)
|
||||
Net
proceeds of offering (note 13)
|
-
|
-
|
29,164
|
|||||||
Exercise
of stock options
|
557
|
148
|
254
|
|||||||
Share
issue expenses
|
-
|
(6
|
)
|
(137
|
)
|
|||||
Redemption
of share capital
|
-
|
-
|
(5
|
)
|
||||||
Resale
of share capital
|
-
|
-
|
23
|
|||||||
142
|
21
|
29,190
|
||||||||
Effect
of foreign exchange rate changes on cash
|
535
|
863
|
(430
|
)
|
||||||
Change
in cash
|
(266
|
)
|
1,960
|
(207
|
)
|
|||||
Cash
- Beginning of year
|
7,119
|
5,159
|
5,366
|
|||||||
Cash
- End of year
|
$
|
6,853
|
$
|
7,119
|
$
|
5,159
|
||||
Supplementary
information
|
||||||||||
Interest
paid
|
$
|
65
|
$
|
30
|
$
|
408
|
||||
Income
taxes paid (recovered)
|
$
|
2,541
|
$
|
(669
|
)
|
$
|
120
|
1. |
Nature
of Activities
|
2. |
Summary
of Significant Accounting
Policies
|
Term
|
|
Land
improvements
|
5
years
|
Buildings
|
25
years
|
Equipment
|
2
to 10 years
|
Leasehold
improvements
|
The
lesser of useful life and remaining lease
term
|
3. |
Business
Combination
|
Assets
acquired
|
||||
Current
assets
|
$
|
5,135
|
||
Property,
plant and equipment
|
3,115
|
|||
Core
technology
|
8,709
|
|||
Current
liabilities assumed
|
(2,826
|
)
|
||
Loans
assumed
|
(402
|
)
|
||
Net
identifiable assets acquired
|
13,731
|
|||
Goodwill
|
5,107
|
|||
Purchase
price, net of cash acquired
|
$
|
18,838
|
4. |
Special
Charges
|
Year
ended August 31, 2006
|
||||||||||||||||
Balance
as at
August
31,
2005
|
Additions
|
Payments
|
Adjustments
|
Balance
as at
August
31,
2006
|
||||||||||||
Fiscal 2006 plan (note 3) | ||||||||||||||||
Severance
expenses
|
$
|
—
|
$
|
660
|
$
|
(29
|
)
|
$
|
—
|
$
|
631
|
|||||
Fiscal 2003 plan | ||||||||||||||||
Exited
leased facilities
|
150
|
—
|
(90
|
)
|
—
|
60
|
||||||||||
Total
for all plans (note 9)
|
$
|
150
|
$
|
660
|
$
|
(119
|
)
|
$
|
—
|
$
|
691
|
Year
ended August 31, 2005
|
||||||||||||||||
Balance
as at
August
31,
2004
|
Additions
|
Payments
|
Adjustments
|
Balance
as at
August
31,
2005
|
||||||||||||
Fiscal
2004 plan
|
||||||||||||||||
Severance
expenses
|
$
|
467
|
$
|
83
|
$
|
(550
|
)
|
$
|
—
|
$
|
—
|
|||||
Other
|
—
|
399
|
(399
|
)
|
—
|
—
|
||||||||||
467
|
482
|
(949
|
)
|
—
|
—
|
|||||||||||
Fiscal
2003 plan
|
||||||||||||||||
Severance
expenses
|
109
|
—
|
(77
|
)
|
(32
|
)
|
—
|
|||||||||
Exited
leased facilities
|
386
|
—
|
(229
|
)
|
(7
|
)
|
150
|
|||||||||
Other
|
197
|
—
|
(46
|
)
|
(151
|
)
|
—
|
|||||||||
692
|
—
|
(352
|
)
|
(190
|
)
|
150
|
||||||||||
Fiscal
2001 plan
|
||||||||||||||||
Exited
leased facilities
|
10
|
—
|
(10
|
)
|
—
|
—
|
||||||||||
Total
for all plans (note 9)
|
$
|
1,169
|
$
|
482
|
$
|
(1,311
|
)
|
$
|
(190
|
)
|
$
|
150
|
Year
ended August 31, 2004
|
||||||||||||||||
Balance
as at
August
31,
2003
|
Additions
|
Payments
|
Adjustments
|
Balance
as at
August
31,
2004
|
||||||||||||
Fiscal
2004 plan
|
||||||||||||||||
Severance
expenses
|
$
|
—
|
$
|
772
|
$
|
(305
|
)
|
$
|
—
|
$
|
467
|
|||||
Fiscal
2003 plan
|
||||||||||||||||
Severance
expenses
|
1,233
|
—
|
(870
|
)
|
(254
|
)
|
109
|
|||||||||
Exited
leased facilities
|
748
|
—
|
(362
|
)
|
—
|
386
|
||||||||||
Other
|
295
|
—
|
(90
|
)
|
(8
|
)
|
197
|
|||||||||
2,276
|
—
|
(1,322
|
)
|
(262
|
)
|
692
|
||||||||||
Fiscal
2002 plans
|
||||||||||||||||
Other
|
68
|
—
|
(68
|
)
|
—
|
—
|
||||||||||
Fiscal
2001 plan
|
||||||||||||||||
Exited
leased facilities
|
124
|
—
|
(72
|
)
|
(42
|
)
|
10
|
|||||||||
Total
for all plans
|
$
|
2,468
|
$
|
772
|
$
|
(1,767
|
)
|
$
|
(304
|
)
|
$
|
1,169
|
5. |
Inventories
|
As
at August 31,
|
2006
|
2005
|
|||||
Raw
materials
|
$
|
14,353
|
$
|
9,373
|
|||
Work
in progress
|
1,043
|
934
|
|||||
Finished
goods
|
9,227
|
7,442
|
|||||
$
|
24,623
|
$
|
17,749
|
6. |
Property,
Plant and Equipment
|
As
at August 31,
|
|
|
|
2006
|
2005
|
||||||||
Cost
|
Accumulated
amortization
|
Cost
|
Accumulated
amortization
|
||||||||||
Land
and land improvements
|
$
|
4,249
|
$
|
1,082
|
$
|
3,179
|
$
|
815
|
|||||
Buildings
|
14,417
|
6,262
|
9,206
|
2,250
|
|||||||||
Equipment
|
33,562
|
28,263
|
33,216
|
29,553
|
|||||||||
Leasehold
improvements
|
2,788
|
2,017
|
2,395
|
1,659
|
|||||||||
55,016
|
$
|
37,624
|
47,996
|
$
|
34,277
|
||||||||
Less:
|
|||||||||||||
Accumulated
amortization
|
37,624
|
34,277
|
|||||||||||
$
|
17,392
|
$
|
13,719
|
7. |
Intangible
Assets and Goodwill
|
As
at August 31,
|
2006
|
2005
|
|||||||||||
Cost
|
Accumulated
amortization
|
Cost
|
Accumulated
amortization
|
||||||||||
Core
technology
|
$
|
47,629
|
$
|
38,972
|
$
|
35,554
|
$
|
32,214
|
|||||
Software
|
6,781
|
4,490
|
6,607
|
4,345
|
|||||||||
54,410
|
$
|
43,462
|
42,161
|
$
|
36,559
|
||||||||
Less:
|
|||||||||||||
Accumulated
amortization
|
43,462
|
36,559
|
|||||||||||
$
|
10,948
|
$
|
5,602
|
As
at August 31,
|
2006
|
2005
|
|||||
Balance
- Beginning of year
|
$
|
20,370
|
$
|
18,393
|
|||
Addition
from business combination (note 3)
|
5,107
|
-
|
|||||
Foreign
currency translation adjustment
|
1,665
|
1,977
|
|||||
Balance
- End of year (note 19)
|
$
|
27,142
|
$
|
20,370
|
8. |
Credit
Facilities
|
9. |
Accounts
Payable and Accrued
Liabilities
|
As
at August 31,
|
2006
|
2005
|
|||||
Trade
|
$
|
7,487
|
$
|
5,781
|
|||
Salaries
and social benefits
|
5,991
|
4,526
|
|||||
Warranty
|
1,006
|
725
|
|||||
Commissions
|
835
|
211
|
|||||
Restructuring
charges (note 4)
|
691
|
150
|
|||||
Business
combination (note 3)
|
185
|
-
|
|||||
Other
|
1,142
|
808
|
|||||
$
|
17,337
|
$
|
12,201
|
As
at August 31,
|
2006
|
2005
|
|||||
Balance
- Beginning of year
|
$
|
725
|
$
|
390
|
|||
Provision
|
895
|
869
|
|||||
Settlements
|
(708
|
)
|
(583
|
)
|
|||
Addition
from business combination
|
31
|
-
|
|||||
Foreign
currency translation adjustment
|
63
|
49
|
|||||
Balance
- End of year
|
$
|
1,006
|
$
|
725
|
10. |
Long-Term
Debt
|
As
at August 31,
|
2006
|
2005
|
|||||
Loans
collateralized by equipment, bearing interest at 4.9%, repayable
in
monthly installments of $10,600 including principal and interest,
maturing
in 2010
|
$
|
461
|
$
|
—
|
|||
Loans
collateralized by equipment, bearing interest at 9.6%, fully repaid
in
fiscal 2006
|
—
|
332
|
|||||
461
|
332
|
||||||
Less:
Current portion
|
107
|
134
|
|||||
$
|
354
|
$
|
198
|
11. |
Commitments
|
12. |
Contingencies
|
13. |
Share
Capital
|
Multiple
voting shares
|
Subordinate
voting shares
|
|||||||||||||||
Number
|
|
Amount
|
|
Number
|
|
Amount
|
|
Total
amount
|
||||||||
Balance
as at August 31, 2003
|
37,900,000
|
$
|
1
|
$
|
25,139,908
|
$
|
492,451
|
492,452
|
||||||||
Public
offering (1)
|
-
|
-
|
5,200,000
|
29,164
|
29,164
|
|||||||||||
Exercise
of stock options (note 14)
|
-
|
-
|
111,071
|
254
|
254
|
|||||||||||
Exercise
of restricted stock awards (note 14)
|
-
|
-
|
89,504
|
-
|
-
|
|||||||||||
Redemption
|
-
|
-
|
(5,340
|
)
|
(5
|
)
|
(5
|
)
|
||||||||
Resale
|
-
|
-
|
5,340
|
5
|
5
|
|||||||||||
Share
issue expenses
|
-
|
-
|
-
|
(137
|
)
|
(137
|
)
|
|||||||||
Balance
as at August 31, 2004
|
37,900,000
|
1
|
30,540,483
|
521,732
|
521,733
|
|||||||||||
Exercise
of stock options (note 14)
|
-
|
-
|
71,699
|
148
|
148
|
|||||||||||
Exercise
of restricted stock awards (note 14)
|
-
|
-
|
53,592
|
-
|
-
|
|||||||||||
Share
issue expenses
|
-
|
-
|
-
|
(6
|
)
|
(6
|
)
|
|||||||||
Balance
as at August 31, 2005
|
37,900,000
|
1
|
30,665,774
|
521,874
|
521,875
|
|||||||||||
Exercise
of stock options (note 14)
|
-
|
-
|
182,425
|
557
|
557
|
|||||||||||
Exercise
of restricted share units (note 14)
|
-
|
-
|
4,770
|
-
|
-
|
|||||||||||
Conversion
of multiple voting shares into subordinate voting shares
|
(757,000
|
)
|
-
|
757,000
|
-
|
-
|
||||||||||
Reclassification
of stock-based compensation cost to share capital upon exercise
of stock
awards
|
-
|
-
|
-
|
200
|
200
|
|||||||||||
Elimination
of deficit by
reduction of share capital (2)
|
-
|
-
|
-
|
(373,711
|
)
|
(373,711
|
)
|
|||||||||
Balance
as at August 31, 2006
|
37,143,000
|
$
|
1
|
31,609,969
|
$
|
148,920
|
$
|
148,921
|
(1)
|
On
February 12, 2004, pursuant to a Canadian public offering, the
company
issued 5,200,000 subordinate voting shares for net proceeds of
$29,164,000
(CA$38,438,400), after deduction of underwriting commission of
$1,215,000
(CA$1,601,000).
|
(2)
|
Upon
the approval of the Board of Directors dated August 31, 2006, the
company
eliminated its deficit against its share
capital.
|
14. |
Stock-Based
Compensation Plans
|
Years
ended August 31,
|
|
2006
|
|
2005
|
|
2004
|
|||||||||||||
|
Number
|
Weighted
Average
exercise
price
(CA$)
|
Number
|
Weighted
average
exercise
price
(CA$)
|
Number
|
Weighted
average
exercise
price
(CA$)
|
|||||||||||||
Outstanding
- Beginning of year
|
2,763,759
|
$
|
19
|
2,934,518
|
$
|
21
|
3,176,613
|
$
|
23
|
||||||||||
Granted
|
31,992
|
6
|
246,233
|
6
|
536,500
|
5
|
|||||||||||||
Exercised
|
(182,425
|
)
|
(4
|
)
|
(71,699
|
)
|
(3
|
)
|
(111,071
|
)
|
(3
|
)
|
|||||||
Forfeited
|
(173,951
|
)
|
(18
|
)
|
(345,293
|
)
|
(27
|
)
|
(667,524
|
)
|
(23
|
)
|
|||||||
Outstanding
- End of year
|
2,439,375
|
$
|
20
|
2,763,759
|
$
|
19
|
2,934,518
|
$
|
21
|
||||||||||
Exercisable
- End of year
|
1,852,870
|
$
|
25
|
1,650,404
|
$
|
28
|
1,331,707
|
$
|
32
|
Years
ended August 31,
|
2006
|
2005
|
2004
|
|||||||
Risk-free
interest rate
|
3.9%
|
|
3.6%
|
|
2.7%
|
|
||||
Expected
volatility (based on historical volatility)
|
87%
|
|
95%
|
|
100%
|
|
||||
Dividend
yield
|
Nil
|
Nil
|
Nil
|
|||||||
Expected
life
|
66
months
|
66
months
|
49
months
|
Stock
options outstanding
|
Stock
options exercisable
|
|||||||||||||||||||||
Exercise
price
(CA$)
|
Number
|
|
Weighted
average
exercise
price
(CA$)
|
|
Aggregate
intrinsic
value
(CA$)
|
|
Weighted
average
remaining
contractual
life
|
|
Number
|
|
Weighted
average
exercise
price
(CA$)
|
|
Aggregate
intrinsic
value
(CA$)
|
|||||||||
$2.50
to $3.36
|
419,655
|
$
|
2.50
|
$
|
1,402
|
6.1
years
|
273,313
|
$
|
2.50
|
$
|
913
|
|||||||||||
$3.96
to $5.84
|
547,687
|
5.07
|
422
|
7.6
years
|
206,464
|
4.92
|
190
|
|||||||||||||||
$6.22
to $9.02
|
193,200
|
6.52
|
—
|
7.4
years
|
94,260
|
6.82
|
—
|
|||||||||||||||
$14.27
to $20.00
|
476,396
|
15.78
|
—
|
5.2
years
|
476,396
|
15.78
|
—
|
|||||||||||||||
$29.70
to $43.00
|
564,436
|
36.27
|
—
|
4.2
years
|
564,436
|
36.27
|
—
|
|||||||||||||||
$51.25
to $68.17
|
199,771
|
65.76
|
—
|
4.0
years
|
199,771
|
65.76
|
—
|
|||||||||||||||
$83.66
|
38,230
|
83.66
|
—
|
4.0
years
|
38,230
|
83.66
|
—
|
|||||||||||||||
2,439,375
|
$
|
20.26
|
$
|
1,824
|
5.7
years
|
1,852,870
|
$
|
25.19
|
$
|
1,103
|
Years
ended August 31,
|
|
2006
|
|
2005
|
|||
Outstanding
- Beginning of year
|
176,185
|
-
|
|||||
Granted
|
173,803
|
176,185
|
|||||
Exercised
|
(4,770
|
)
|
-
|
||||
Forfeited
|
(17,341
|
)
|
-
|
||||
Outstanding
- End of year
|
327,877
|
176,185
|
Years
ended August 31,
|
2006
|
2005
|
|||||
Outstanding
- Beginning of year
|
23,734
|
-
|
|||||
Granted
|
19,556
|
23,734
|
|||||
Outstanding
- End of year
|
43,290
|
23,734
|
Years
ended August 31,
|
|
|
2006
|
|
|
|
2005
|
|
|
|
2004
|
|
|||||||
|
|
|
|
Weighted
|
|
|
|
Weighted
|
|
|
|
Weighted
|
|
||||||
|
|
|
|
average
|
|
|
|
average
|
|
|
|
average
|
|
||||||
|
|
|
|
exercise
|
|
|
|
exercise
|
|
|
|
exercise
|
|
||||||
|
|
Number
|
|
price
|
|
Number
|
|
price
|
|
Number
|
|
price
|
|||||||
Outstanding
- Beginning of year
|
19,000
|
$
|
12
|
13,000
|
$
|
16
|
9,000
|
$
|
24
|
||||||||||
Granted
|
5,500
|
6
|
6,000
|
4
|
6,000
|
5
|
|||||||||||||
Forfeited
|
-
|
-
|
-
|
-
|
(2,000
|
)
|
(19
|
)
|
|||||||||||
Outstanding
- End of year
|
24,500
|
$
|
11
|
19,000
|
$
|
12
|
13,000
|
$
|
16
|
||||||||||
Exercisable
- End of year
|
11,000
|
$
|
18
|
7,500
|
$
|
24
|
4,250
|
$
|
30
|
Stock
appreciation
rights
outstanding
|
Stock
appreciation
rights
exercisable
|
|||||||||
Exercise
price
|
Number
|
Weighted
average
remaining
contractual
life
|
Number
|
|||||||
$2.21
|
2,000
|
6.6
years
|
1,500
|
|||||||
$4.51
to $6.50
|
17,500
|
8.4
years
|
4,500
|
|||||||
$22.25
|
2,500
|
4.4
years
|
2,500
|
|||||||
$45.94
|
2,500
|
4.0
years
|
2,500
|
|||||||
24,500
|
7.4
years
|
11,000
|
Years
ended August 31,
|
2005
|
2004
|
|||||
Outstanding
- Beginning of year
|
53,592
|
143,096
|
|||||
Exercised
|
(53,592
|
)
|
(89,504
|
)
|
|||
Outstanding
- End of year
|
-
|
53,592
|
15. |
Other
Disclosures
|
Years
ended August 31,
|
2006
|
2005
|
2004
|
|||||||
Gross
research and development expenses
|
$
|
19,488
|
$
|
15,878
|
$
|
15,668
|
||||
Research
and development tax credits and grants
|
(4,084
|
)
|
(3,688
|
)
|
(3,278
|
)
|
||||
$
|
15,404
|
$
|
12,190
|
$
|
12,390
|
• |
Deferred
profit-sharing plan
|
The
company maintains a plan for certain eligible Canadian resident
employees,
under which the company may elect to contribute an amount equal
to 2% (1%
prior to June 2005) of an employee’s gross salary, provided that the
employee has contributed at least 2% of his/her gross salary to
a
tax-deferred registered retirement savings plan. Cash contributions
to
this plan and expenses for the years ended August 31, 2004, 2005
and 2006,
amounted to CA$141,000 (US$106,000), CA$221,000 (US$179,000) and
CA$363,000 (US$316,000),
respectively.
|
• |
401K
plan
|
The
company maintains a 401K plan for eligible U.S. resident employees.
Under
this plan, the company must contribute an amount equal to 3% of
an
employee’s current compensation. During the years ended August 31, 2004,
2005 and 2006, the company recorded cash contributions and expenses
totaling $187,000, $134,000 and $126,000,
respectively.
|
16. |
Income
Taxes
|
Years
ended August 31,
|
2006
|
2005
|
2004
|
|||||||
Income
tax provision at combined Canadian federal and provincial statutory
tax
rate (32% in 2006, 31% in 2005 and 32% in 2004)
|
$
|
3,430
|
$
|
307
|
$
|
(3,011
|
)
|
|||
Increase
(decrease) due to:
|
||||||||||
Foreign
income taxed at different rates
|
(85
|
)
|
(580
|
)
|
(767
|
)
|
||||
Non-taxable
income
|
(207
|
)
|
(827
|
)
|
(128
|
)
|
||||
Non-deductible
expenses
|
527
|
784
|
1,205
|
|||||||
Tax
deductions
|
-
|
(81
|
)
|
(169
|
)
|
|||||
Change
in enacted rates
|
497
|
-
|
274
|
|||||||
Effect
of consolidation of subsidiaries
|
61
|
(209
|
)
|
(1,384
|
)
|
|||||
Previous
year tax recovery
|
-
|
-
|
(1,406
|
)
|
||||||
Other
|
239
|
(146
|
)
|
446
|
||||||
Change
in valuation allowance
|
(1,877
|
)
|
3,375
|
3,954
|
||||||
$
|
2,585
|
$
|
2,623
|
$
|
(986
|
)
|
||||
The
income tax provision consists of the following:
|
||||||||||
Current
|
||||||||||
Canadian
|
$
|
2,573
|
$
|
2,513
|
$
|
(577
|
)
|
|||
Other
|
12
|
110
|
(409
|
)
|
||||||
2,585
|
2,623
|
(986
|
)
|
|||||||
Future
|
||||||||||
Canadian
|
2,687
|
(1,445
|
)
|
(1,104
|
)
|
|||||
United
States
|
(601
|
)
|
(1,723
|
)
|
(2,448
|
)
|
||||
Other
|
(209
|
)
|
(207
|
)
|
(402
|
)
|
||||
1,877
|
(3,375
|
)
|
(3,954
|
)
|
||||||
Valuation
allowance
|
||||||||||
Canadian
|
(2,687
|
)
|
1,445
|
1,104
|
||||||
United
States
|
601
|
1,723
|
2,448
|
|||||||
Other
|
209
|
207
|
402
|
|||||||
(1,877
|
)
|
3,375
|
3,954
|
|||||||
$
|
2,585
|
$
|
2,623
|
$
|
(986
|
)
|
||||
Details
of the company’s income taxes:
|
||||||||||
Earnings
(loss) before income taxes
|
||||||||||
Canadian
|
$
|
13,202
|
$
|
3,092
|
$
|
(7,740
|
)
|
|||
United
States
|
(2,103
|
)
|
(953
|
)
|
(5,879
|
)
|
||||
Other
|
(379
|
)
|
(1,150
|
)
|
4,209
|
|||||
$
|
10,720
|
$
|
989
|
$
|
(9,410
|
)
|
As
at August 31,
|
2006
|
2005
|
|||||
Future
income tax assets
|
|||||||
Long-lived
assets
|
$
|
4,453
|
$
|
4,902
|
|||
Provisions
and accruals
|
7,315
|
7,406
|
|||||
Government
grants
|
-
|
209
|
|||||
Deferred
revenue
|
486
|
318
|
|||||
Share
issue expenses
|
531
|
590
|
|||||
Research
and development expenses
|
8,527
|
7,292
|
|||||
Losses
carried forward
|
18,118
|
18,424
|
|||||
39,430
|
39,141
|
||||||
Valuation
allowance
|
(38,543
|
)
|
(38,406
|
)
|
|||
887
|
735
|
||||||
Future
income tax liabilities
|
|||||||
Research
and development tax credits
|
(887
|
)
|
(735
|
)
|
|||
Future
income tax assets, net
|
$
|
-
|
$
|
-
|
Canada
|
United
States
|
|||||||||
Year
of expiry
|
Federal
|
Provinces
|
and
Other
|
|||||||
2008
|
$
|
1,252
|
$
|
92
|
$
|
1,857
|
||||
2009
|
5,186
|
394
|
599
|
|||||||
2010
|
4,677
|
327
|
266
|
|||||||
2011
|
168
|
86
|
-
|
|||||||
2013
|
-
|
-
|
876
|
|||||||
2015
|
1,666
|
1,670
|
-
|
|||||||
2022
|
-
|
-
|
9,406
|
|||||||
2023
|
-
|
-
|
11,621
|
|||||||
2024
|
-
|
-
|
6,700
|
|||||||
2025
|
-
|
-
|
6,690
|
|||||||
2026
|
1,694
|
1,696
|
2,737
|
|||||||
Indefinite
|
1,702
|
1,775
|
1,996
|
|||||||
$
|
16,345
|
$
|
6,040
|
$
|
42,748
|
17. |
Earnings
per Share
|
Years
ended August 31,
|
2006
|
2005
|
2004
|
|||||||
Basic
weighted average number of shares outstanding (000’s)
|
68,643
|
68,526
|
66,020
|
|||||||
Plus
dilutive effect of:
|
||||||||||
Stock
options (000’s)
|
502
|
422
|
502
|
|||||||
Deferred
share units (000’s)
|
31
|
8
|
-
|
|||||||
Restricted
share units (000’s)
|
99
|
8
|
-
|
|||||||
Restricted
stock awards (000’s)
|
—
|
17
|
93
|
|||||||
Diluted
weighted average number of shares outstanding (000’s)
|
69,275
|
68,981
|
66,615
|
|||||||
Stock
awards excluded from the calculation of the diluted weighted average
number of shares outstanding because their exercise price was greater
than
the average market price of the common shares (000’s)
|
1,628
|
1,962
|
2,128
|
18. |
Financial
Instruments
|
As
at August 31,
|
2006
|
2005
|
|||||
Commercial
paper denominated in Canadian dollars, bearing interest at annual
rates of
3.92% to 4.31% in 2006 and 2.44% to 2.75% in 2005, maturing on
different
dates between September 2006 and January 2007 in fiscal 2006, and
September 2005 and January 2006 in fiscal 2005
|
$
|
104,437
|
$
|
104,883
|
Cash
|
Non-interest
bearing
|
Short-term
investments
|
As
described above
|
Accounts
receivable
|
Non-interest
bearing
|
Accounts
payable and accrued liabilities
|
Non-interest
bearing
|
Long-term
debt
|
As
described in note 10
|
Contractual
amounts
|
|
Weighted
average contractual forward rates
|
|||||
As
at August 31, 2005
|
|||||||
September
2005 to August 2006
|
$
|
26,000
|
1.2630
|
||||
September
2006 to November 2007
|
7,600
|
1.2500
|
|||||
As
at August 31, 2006
|
|||||||
September
2006 to August 2007
|
$
|
37,000
|
1.1676
|
||||
September
2007 to June 2009
|
26,800
|
1.1261
|
19. |
Segment
Information
|
Year
ended August 31, 2006
|
Telecom
Division
|
Life
Sciences and
Industrial
Division
|
Total
|
|||||||
Sales
|
$
|
107,376
|
$
|
20,877
|
$
|
128,253
|
||||
Earnings
from operations
|
$
|
6,679
|
$
|
1,383
|
$
|
8,062
|
||||
Unallocated
items:
|
||||||||||
Interest
and other income
|
3,253
|
|||||||||
Foreign
exchange loss
|
(595
|
)
|
||||||||
Earnings
before income taxes
|
10,720
|
|||||||||
Income
taxes
|
2,585
|
|||||||||
Net
earnings for the year
|
$
|
8,135
|
||||||||
Government
grants (note 15)
|
$
|
(1,307
|
)
|
$
|
—
|
$
|
(1,307
|
)
|
||
Amortization
of capital assets
|
$
|
6,689
|
$
|
1,228
|
$
|
7,917
|
||||
Stock-based
compensation costs
|
$
|
962
|
$
|
70
|
$
|
1,032
|
||||
Impairment
of long-lived assets (note 4)
|
$
|
—
|
$
|
604
|
$
|
604
|
||||
Capital
expenditures
|
$
|
3,049
|
$
|
329
|
$
|
3,378
|
Year
ended August 31, 2005
|
Telecom
Division
|
Life
Sciences and
Industrial
Division
|
Total
|
|||||||
Sales
|
$
|
80,120
|
$
|
17,096
|
$
|
97,216
|
||||
Earnings
(loss) from operations
|
$
|
763
|
$
|
(962
|
)
|
$
|
(199
|
)
|
||
Unallocated
items:
|
||||||||||
Interest
and other income
|
2,524
|
|||||||||
Foreign
exchange loss
|
(1,336
|
)
|
||||||||
Earnings
before income taxes
|
989
|
|||||||||
Income
taxes
|
2,623
|
|||||||||
Net
loss for the year
|
$
|
(1,634
|
)
|
|||||||
Amortization
of capital assets
|
$
|
6,504
|
$
|
2,588
|
$
|
9,092
|
||||
Stock-based
compensation costs
|
$
|
897
|
$
|
66
|
$
|
963
|
||||
Capital
expenditures
|
$
|
1,408
|
$
|
93
|
$
|
1,501
|
Year
ended August 31, 2004
|
Telecom
Division
|
Life
Sciences and
Industrial
Division
|
Total
|
|||||||
Sales
|
$
|
58,882
|
$
|
15,748
|
$
|
74,630
|
||||
Loss
from operations
|
$
|
(5,557
|
)
|
$
|
(5,013
|
)
|
$
|
(10,570
|
)
|
|
Unallocated
items:
|
||||||||||
Interest
and other income
|
1,438
|
|||||||||
Foreign
exchange loss
|
(278
|
)
|
||||||||
Loss
before income taxes
|
(9,410
|
)
|
||||||||
Income
taxes
|
(986
|
)
|
||||||||
Net
loss for the year
|
$
|
(8,424
|
)
|
|||||||
Amortization
of capital assets
|
$
|
6,643
|
$
|
3,372
|
$
|
10,015
|
||||
Stock-based
compensation costs
|
$
|
417
|
$
|
32
|
$
|
449
|
||||
Impairment
of long-lived assets (note 4)
|
$
|
620
|
$
|
—
|
$
|
620
|
||||
Restructuring
and other charges (note 4)
|
$
|
—
|
$
|
1,261
|
$
|
1,261
|
||||
Capital
expenditures
|
$
|
607
|
$
|
244
|
$
|
851
|
As
at August 31,
|
2006
|
2005
|
|||||
Telecom
Division
|
$
|
93,853
|
$
|
64,655
|
|||
Life
Sciences and Industrial Division
|
11,339
|
11,449
|
|||||
Unallocated
assets
|
113,967
|
114,853
|
|||||
$
|
219,159
|
$
|
190,957
|
As
at August 31,
|
2006
|
2005
|
|||||
Telecom
Division
|
$
|
22,545
|
$
|
16,092
|
|||
Life
Sciences and Industrial Division
|
4,597
|
4,278
|
|||||
$
|
27,142
|
$
|
20,370
|
Years
ended August 31,
|
2006
|
2005
|
2004
|
|||||||
United
States
|
$
|
59,457
|
$
|
56,282
|
$
|
40,019
|
||||
Canada
|
8,767
|
6,830
|
5,818
|
|||||||
Latin
America
|
8,380
|
3,127
|
3,547
|
|||||||
76,604
|
66,239
|
49,384
|
||||||||
Europe,
Middle East and Africa
|
32,379
|
19,396
|
13,706 | |||||||
Asia-Pacific
|
19,270
|
11,581
|
11,540
|
|||||||
$
|
128,253
|
$
|
97,216
|
$
|
74,630
|
As
at August 31,
|
2006
|
2005
|
|||||
Canada
|
$
|
51,724
|
$
|
35,690
|
|||
United
States
|
3,758
|
5,601
|
|||||
$
|
55,482
|
$
|
41,291
|
20. |
United
States Generally Accepted Accounting
Principles
|
Years
ended August 31,
|
2006
|
2005
|
2004
|
|||||||
Net
earnings (loss) for the year in accordance with Canadian GAAP
|
$
|
8,135
|
$
|
(1,634
|
)
|
$
|
(8,424
|
)
|
||
Stock-based
compensation costs
|
a) |
-
|
-
|
(867
|
)
|
|||||
Unrealized
losses on forward exchange contracts
|
b) |
-
|
(1,286
|
)
|
(280
|
)
|
||||
Net
earnings (loss) for the year in accordance with U.S. GAAP
|
8,135
|
(2,920
|
)
|
(9,571
|
)
|
|||||
Other
comprehensive income (loss)
|
||||||||||
Foreign
currency translation adjustment
|
12,322
|
15,669
|
5,969
|
|||||||
Unrealized
gains on forward exchange contracts
|
b) |
5,394
|
2,313
|
689
|
||||||
Reclassification
of realized gains on forward exchange contracts
in
net earnings (loss)
|
b) |
(2,880
|
)
|
(65
|
)
|
-
|
||||
Comprehensive
income (loss)
|
$
|
22,971
|
$
|
14,997
|
$
|
(2,913
|
)
|
|||
Basic
and diluted net earnings (loss) per share in accordance with
U.S. GAAP
|
$
|
0.12
|
$
|
(0.04
|
)
|
$
|
(0.14
|
)
|
||
Basic
weighted average number of shares outstanding (000’s)
|
68,643
|
68,526
|
66,020
|
|||||||
Diluted
weighted average number of shares outstanding (000’s)
|
69,275
|
68,981
|
66,615
|
As
at August 31,
|
2006
|
2005
|
2004
|
|||||||
Shareholders’
equity in accordance with Canadian GAAP
|
$
|
196,234
|
$
|
173,400
|
$
|
157,327
|
||||
Forward
exchange contracts
|
b) |
5,451
|
2,937
|
1,975
|
||||||
Goodwill
|
(11,908
|
)
|
(11,042
|
)
|
(10,008
|
)
|
||||
Shareholders’
equity in accordance with U.S. GAAP
|
$
|
189,777
|
$
|
165,295
|
$
|
149,294
|
Share
capital
|
Contributed
surplus
|
Deficit
|
Deferred
stock-based compensation costs
|
Other
capital
|
Accumulated
other comprehensive income
|
Shareholders’
equity
|
||||||||||||||||
Balance
as at August 31, 2003
|
$
|
565,291
|
$
|
1,519
|
$
|
(454,588
|
)
|
$
|
(1,278
|
)
|
$
|
5,429
|
$
|
5,219
|
$
|
121,592
|
||||||
Net
loss for the year
|
—
|
—
|
(9,571
|
)
|
—
|
—
|
—
|
(9,571
|
)
|
|||||||||||||
Stock-based
compensation costs
|
1,737
|
—
|
—
|
339
|
(760
|
)
|
—
|
1,316
|
||||||||||||||
Foreign
currency translation adjustment
|
—
|
—
|
—
|
—
|
—
|
5,969
|
5,969
|
|||||||||||||||
Unrealized
gains on forward exchange contracts
|
—
|
—
|
—
|
—
|
—
|
689
|
689
|
|||||||||||||||
Public
offering (note 13)
|
29,164
|
—
|
—
|
—
|
—
|
—
|
29,164
|
|||||||||||||||
Exercise
of stock options (note 13)
|
254
|
—
|
—
|
—
|
—
|
—
|
254
|
|||||||||||||||
Share
issue expenses (note 13)
|
(137
|
)
|
—
|
—
|
—
|
—
|
—
|
(137
|
)
|
|||||||||||||
Premium
on resale of share capital
|
—
|
18
|
—
|
—
|
—
|
—
|
18
|
|||||||||||||||
Balance
as at August 31, 2004
|
596,309
|
1,537
|
(464,159
|
)
|
(939
|
)
|
4,669
|
11,877
|
149,294
|
|||||||||||||
Net
loss for the year
|
—
|
—
|
(2,920
|
)
|
—
|
—
|
—
|
(2,920
|
)
|
|||||||||||||
Stock-based
compensation costs
|
1,213
|
—
|
—
|
(776
|
)
|
425
|
—
|
862
|
||||||||||||||
Foreign
currency translation adjustment
|
—
|
—
|
—
|
—
|
—
|
15,669
|
15,669
|
|||||||||||||||
Unrealized
gains on forward exchange contracts
|
—
|
—
|
—
|
—
|
—
|
2,248
|
2,248
|
|||||||||||||||
Exercise
of stock options (note 13)
|
148
|
—
|
—
|
—
|
—
|
—
|
148
|
|||||||||||||||
Share
issue expenses (note 13)
|
(6
|
)
|
—
|
—
|
—
|
—
|
—
|
(6
|
)
|
|||||||||||||
Balance
as at August 31, 2005
|
597,664
|
1,537
|
(467,079
|
)
|
(1,715
|
)
|
5,094
|
29,794
|
165,295
|
|||||||||||||
Net
earnings for the year
|
—
|
—
|
8,135
|
—
|
—
|
—
|
8,135
|
|||||||||||||||
Stock-based
compensation costs
|
—
|
—
|
—
|
344
|
610
|
—
|
954 | |||||||||||||||
Foreign
currency translation adjustment
|
—
|
—
|
—
|
—
|
—
|
12,322
|
12,322
|
|||||||||||||||
Unrealized
gains on forward exchange contracts
|
—
|
—
|
—
|
—
|
—
|
2,514
|
2,514
|
|||||||||||||||
Exercise
of stock options
|
557
|
—
|
—
|
—
|
—
|
—
|
557
|
|||||||||||||||
Reclassification
of stock-based compensation costs upon exercise of stock awards
(note 13)
|
200
|
—
|
—
|
—
|
(200
|
)
|
—
|
—
|
||||||||||||||
Balance
as at August 31, 2006
|
$
|
598,421
|
$
|
1,537
|
$
|
(458,944
|
)
|
$
|
(1,371
|
)
|
$
|
5,504
|
$
|
44,630
|
$
|
189,777
|
As
at August 31,
|
2006
|
|
2005
|
|
2004
|
|||||
Foreign
currency translation adjustment
|
||||||||||
Current
year
|
$
|
12,322
|
$
|
15,669
|
$
|
5,969
|
||||
Cumulative
effect of prior years
|
26,857
|
11,188
|
5,219
|
|||||||
39,179
|
26,857
|
11,188
|
||||||||
Unrealized
gains on forward exchange contracts
|
b) | |||||||||
Current
year
|
2,514
|
2,248
|
689
|
|||||||
Cumulative
effect of prior years
|
2,937
|
689
|
—
|
|||||||
5,451
|
2,937
|
689
|
||||||||
$
|
44,630
|
$
|
29,794
|
$
|
11,877
|
Germain
Lamonde
Chairman
of the Board,
President
and CEO, EXFO
Electro-Optical
Engineering Inc.
Germain
Lamonde, a company founder, has been Chairman of the Board, President
and
CEO of EXFO since its inception in his apartment in 1985. Mr.
Lamonde, who
is responsible for the overall management and strategic direction
of EXFO
and its subsidiaries and divisions, has grown the company from
the ground
up into a global leader in the telecommunications test and measurement
industry. Mr. Lamonde has served on the boards of several organizations
such as the Canadian Institute for Photonic Innovations, the
Pole QCA
Economic Development Corporation and the National Optics Institute
of
Canada to name a few. Germain Lamonde holds a bachelor’s degree in physics
engineering from the University of Montreal’s School of Engineering (École
Polytechnique), a master’s degree in optics from Laval University, and is
also a graduate of the Ivey Executive Program offered by the
University of
Western Ontario.
|
Dr.
David A. Thompson 2
Vice-President
and Director
Hardware
& Equipment Technology
Corning
Cable Systems
Dr.
David A. Thompson is Vice-President and Director of Hardware
&
Equipment Technology at Corning Cable Systems, where he has held
this
position since January 2006. Prior to this, he was Vice-President
and
Director of Hardware & Equipment Technology Strategy for Corning Cable
Systems from January 2002 to December 2005. Dr. Thompson first
joined
Corning Incorporated in 1976 and later took on several technology
directorship and strategic planning roles. His last position
at Corning
prior to transferring to Corning Cable Systems in January 2002 was
Division Vice-President for the Strategic Planning & Innovation
Effectiveness in Research, Development and Engineering. Dr. David
Thompson
holds a bachelor’s degree in chemistry from Ohio State University and a
doctorate in inorganic chemistry from the University of
Michigan.
|
|||
Pierre
Marcouiller 1,2
Chairman
of the Board and CEO,
Camoplast
Inc.
Pierre
Marcouiller is Chairman of the Board and CEO of Camoplast Inc.,
an
industrial manufacturer specializing in rubber tracks, molded
composites,
thermoplastic components and off-road tracked vehicles. Prior
to joining
Camoplast, Mr. Marcouiller was President and General Manager
of Venmar
Ventilation Inc. (1988-1996), where he was the controlling shareholder
from 1991 to 1996. Mr. Marcouiller is also a Director of Héroux- Devtek
Inc., a public company specialized in the design, development
and
manufacturing of aerospace, defense and industrial products.
Pierre
Marcouiller holds a bachelor’s degree in business administration from the
Université
du Québec à Trois-Rivières and
an MBA from the Université
de Sherbrooke.
|
André
Tremblay 1,2
Founder
and Managing Partner, Trio Capital
André
Tremblay is a Founder and Managing Partner of Trio Capital Inc.,
a private
equity fund management company. He has more than 20 years’ experience in
the telecommunications industry, having been actively involved
in the
conception, financing and management of several companies. As
a special
advisor to the President of Telesystem Ltd., and as President
of
Telesystem Enterprises Ltd. from 1992 to 1998, he managed a portfolio
of
telecommunication companies under control. For almost 10 years,
he served
as President and Chief Executive Officer of Microcell Telecommunications,
a wireless network and service provider, which he led from its
inception
on through the different phases of its evolution. During that
time, he has
also provided early-stage financing, along with strategic advice
and
direction, for start-up technology firms. In 2005, he was appointed
by
Canada’s Industry Minister as member of the Telecommunications Policy
Review Panel to make recommendations on how to modernize Canada’s
telecommunication policies and regulatory framework. André Tremblay holds
bachelor’s degrees in management and in accounting from Laval University,
a master’s degree in taxation from the Université
de Sherbrooke,
and is also a graduate of Harvard Business School’s Advanced Management
Program.
|
|||
Guy
Marier 1,2
Corporate
Director
Formerly
President of Bell Québec (1999 to 2003), Guy Marier completed his
successful 33-year career at Bell as Executive Vice-President
of the
Project Management Office before retiring at the end of 2003.
From 1988 to
1990, Mr. Marier headed Bell Canada International’s investments and
projects in Saudi Arabia and, for the three following years,
served as
President of Télébec. He then returned to the parent company to hold
various senior management positions. Mr. Marier currently sits
on the
board of Bell Nordiq, a wholly-owned subsidiary of Bell Canada.
Guy Marier
holds a Bachelor of Arts from the University of Montreal and
a Bachelor of
Business Administration from the Université
du Québec à Montréal.
|
Michael
Unger 1,2,3
Executive
Consultant
Michael
Unger had a distinguished career with Nortel Networks (1962 to
2000),
where he held a number of key executive positions in the switching
and
transmission business units over the years. Mr. Unger’s most recent
position was President of Nortel’s Optical Networks Business Unit (1998 to
2000). Prior to this appointment, he was Nortel’s Group Vice-President,
Transport Networks (1990 to 1998). Currently, Mr. Unger serves
on the
boards of directors and committees of several companies active
in the
areas of network management software, photonic and optical components,
optical network systems and solutions for cable operators, as
well as
other communications network service providers. Namely, he is
a board
member and chairs the audit committee of Nakina Systems, and
he is also
part of the board of directors and human resources committee
of Tundra
Semiconductor Corporation. Michael Unger holds a Bachelor of
Science from
Concordia University and has successfully completed several accounting
credits, also given by Concordia University in Montreal, Canada.
In
addition, Mr. Unger holds an executive MBA from the University
of Western
Ontario.
|
Germain
Lamonde
Chairman,
President and
Chief
Executive Officer
|
Étienne
Gagnon
Vice-President,
Product Management
Optical
and Protocol Products
|
|||
Stephen
Bull
Vice-President,
Research and Development
Telecom
Division
|
Luc
Gagnon
Vice-President,
Telecom
Manufacturing
Operations
|
|||
Normand
Durocher
Vice-President
Human
Resources
|
Juan
Felipe González
Vice-President,
Telecom Sales
International
|
|||
Allan
Firhoj
Vice-President
and General Manager
Life
Sciences and Industrial Division
|
Pierre
Plamondon, CA
Vice-President,
Finance and
Chief
Financial Officer
|
|||
Robert
Fitts
Vice-President,
Product Management
Copper
Access Products
|
Dana
Yearian
Vice-President,
Telecom Sales
North
America
|
|||
Benoît
Ringuette
Legal
Counsel and
Corporate
Secretary
|
Canada
|
United
States
|
CIBC
Mellon Trust Company
|
Mellon
Investor Services, LLC
|
2001
University Street
|
Overpeck
Center
|
Suite
1600
|
85
Challenger Road
|
Montreal,
Quebec H3A 2A6
|
Ridgefield
Park, New Jersey 07660
|
Tel.:
(514) 285-3600
|
Tel.:
(201) 296-4000
|
General
Access
|
Investor
Relations
|
EXFO
Electro-Optical Engineering Inc.
|
Vance
Oliver
|
400
Godin Avenue
|
Manager,
Investor Relations
|
Quebec,
Quebec G1M 2K2
|
Tel.:
(418) 683-0913, Ext. 3733
|
Tel.:
(418) 683-0211
|
E-mail:
vance.oliver@exfo.com
|
E-mail:
ir@exfo.com
www.EXFO.com
|
EXFO
Corporate Headquarters
400
Godin Avenue
Quebec
City (Quebec) G1M 2K2 CANADA
Tel.:
1 800 663-3936 (USA and Canada)
or
1 418 683-0211 Fax: 1 418 683-2170
|
EXFO
Europe
Omega
Enterprise Park, Electron Way
Chandlers
Ford, Hampshire S053 4SE ENGLAND
Tel.:
+44 2380 246810 Fax: +44 2380 246801
|
EXFO
Protocol
2650
Marie-Curie West
St-Laurent
(Quebec) H4S 2C3 CANADA
Tel.:
1 888 972-7666 (USA and Canada)
or
1 514 856-2222 Fax: 1 514 856-2232
|
EXFO
Asia
151
Chin Swee Road, #03-29
Manhattan
House SINGAPORE 169876
Tel.:
+65 6333 8241 Fax: +65 6333 8242
|
EXFO
Photonic Solutions Inc.
2260
Argentia Road
Mississauga
(Ontario) L5N 6H7 CANADA
Tel.:
(905) 821-2600 Fax: (905) 821-2055
|
EXFO
China
No.88
Fuhua First Road
Central
Tower, Room 801
Futian
District
Shenzhen
518048, P.R. CHINA
Tel.:
+86 (755) 8203 2300 Fax: +86 (755) 8203 2306
|
EXFO
Consultronics
160
Drumlin Circle
Concord
(Ontario) L4K 3E5 Canada
Tel:
905-738-3741 Fax: 905-738-3712
|
Beijing
New Century Hotel Office Tower
Room
1754-1755
No.
6 Southern Capital Gym Road
Beijing
100044 P. R. CHINA
Tel.:
+86 (10) 6849 2738 Fax: +86 (10) 6849 2662
|
EXFO
America
3701
Plano Parkway, Suite 160
Plano,
TX 75075 USA
Tel.:
1 800 663-3936
or
1 972 907-1505 Fax: 1 972 836-0164
|
EXFO
Japan
4-6-3-202
Akasaka, Minato-ku
Tokyo
107-0052, JAPAN
Tel.:
+81-3-5562-5344 Fax:
+81-3-5562-5777
|
Telecom
Test and Measurement
|
www.EXFO.com
|
|
©
2006
EXFO Electro-Optical Engineering Inc. All rights
reserved. Printed in Canada.
|
· |
Increased
sales 31.9% to $128.3 million in 2006 mainly through organic
growth;
|
· |
Delivered
sales growth of 34.0% and 22.1% year-over-year for our Telecom Division
and Life Sciences & Industrial Division,
respectively;
|
· |
Posted
sales CAGRs of 27.5% and 20.9% over the last three and ten years,
respectively, despite a major telecom crisis in 2001;
|
· |
Achieved
GAAP net earnings of $8.1 million and GAAP operating margin of
6.3%;
|
· |
Generated
$0.31 in earnings before income taxes for every additional dollar
of
revenue in 2006 over 2005;
|
· |
Produced
$12.3 million in cash flows from operating
activities;
|
· |
Derived
37.1% of sales from new products on the market two years or
less;
|
· |
Acquired
Consultronics for $19.1 million in cash, strategically positioning
EXFO
for the triple-play, broadband access test
market;
|
· |
Consolidated
leadership position in the portable optical test market with a third
consecutive Growth Strategy Leadership Award from Frost & Sullivan for
achieving highest organic market-share
gains;
|
· |
Posted
best sales and bookings year in company history for protocol business,
which is growing much faster than our Telecom Division;
and
|
· |
Received
Product Differentiation Innovation Award from Frost & Sullivan for new
portfolio of protocol test solutions dedicated to next-generation
and
traditional SONET/SDH networks.
|
· |
Grow
revenues by 20% year-over-year;
|
· |
Generate
a GAAP operating margin of 7%; and
|
· |
Derive
35% of sales from new products (on the market two years or
less).
|
1. |
to
receive the consolidated financial statements of the Corporation
for the
financial year ended August 31, 2006, and the Auditor’s report
thereon;
|
2. |
to
elect Directors of the Corporation;
|
3. |
to
appoint PricewaterhouseCoopers LLP as auditors and to authorize the
Audit
Committee to fix their remuneration;
|
4. |
to
transact such further or other business as may properly come before
the
Meeting or any adjournment or adjournments
thereof.
|
o
(A)
|
Mr.
Germain Lamonde of Cap-Rouge, Quebec, or failing him, Mr. Pierre
Plamondon
of Quebec, Quebec;
|
To
elect Germain Lamonde, Pierre Marcouiller, Guy Marier, David A.
Thompson,
André Tremblay and Michael Unger, whose cities of residence are indicated
in the Management Proxy Circular, as Directors of the
Corporation.
|
FOR
ABSTENTION
|
o
o
|
To
appoint PricewaterhouseCoopers LLP as auditors and to authorize
the Audit
Committee to fix their remuneration.
|
FOR
ABSTENTION
|
o
o
|
*
A shareholder is entitled to appoint, to attend and act for and
on behalf
of such shareholder at the Meeting, a person other than the person
mentioned in (A) herein above and may do so by checking (B) hereinabove
and adding the name of such other person in the space reserved
for such
purpose.
|
DATED
this day of
__________________________________________
SIGNATURE
OF SHAREHOLDER
[ ]
name
of shareholder
[
]
|
Name
of Shareholder
|
Number
of Subordinate Voting Shares
|
Percentage
of Voting Rights Attached to All Subordinate Voting
Shares
|
Number
of Multiple Voting Shares (1)
|
Percentage
of Voting Rights Attached to All Multiple Voting
Shares
|
Percentage
of Voting Rights Attached to All Subordinate and Multiple Voting
Shares
|
Germain
Lamonde
|
483,500(2)
|
1.53%
|
37,143,000(3)
|
100%
|
92.27%
|
FMR
Corporation
|
4,624,700(4)
|
14.62%
|
-
|
-
|
1.15%
|
Kern
Capital Management LLC
|
4,596,700(5)
|
14.53%
|
-
|
-
|
1.14%
|
(1) |
The
holder of Multiple Voting Shares is entitled to 10 votes for each
share.
|
(2) |
Mr.
Lamonde exercises control over this number of Subordinate Voting
Shares
through G. Lamonde Investissements Financiers inc., a company
controlled by Mr. Lamonde.
|
(3) |
Mr.
Lamonde exercises control over this number of Multiple Voting Shares
through G. Lamonde Investissements Financiers inc., a company
controlled by Mr. Lamonde and through Fiducie Germain Lamonde, a
family
trust for the benefit of Mr. Lamonde’s
family.
|
(4) |
As
of September 30, 2006, Fidelity
Management and Research Company, a wholly-owned subsidiary of FMR
Corporation, is the beneficial owner of this number of subordinate
voting
shares as a result of acting as investment advisor to various investment
companies.
|
(5) |
As
of September 30, 2006, Kern Capital Management LLC controls the voting
rights attached to this number of subordinate voting shares through
relationships with several clients and does not beneficially own
directly
this number of subordinate voting
shares.
|
Name
and Position or Office with the Corporation
|
Principal
Occupation or Employment
|
Residence
|
Director
Since
|
Number
of Subordinate Voting Shares
|
Number
of Multiple Voting Shares
|
Germain
Lamonde
Chairman
of the Board, President and Chief Executive Officer
|
Chairman
of the Board, President and Chief Executive Officer, EXFO Electro-Optical
Engineering Inc.
|
Cap-Rouge,
Quebec,
Canada
|
September
1985
|
483,500(1)
|
37,143,000(2)
|
Name
and Position or Office with the Corporation
|
Principal
Occupation or Employment
|
Residence
|
Director
Since
|
Number
of Subordinate Voting Shares
|
Number
of Multiple Voting Shares
|
Pierre
Marcouiller(3)
(4)
Independent
Director
|
Chairman
of the Board and Chief Executive Officer,
Camoplast
Inc. (a supplier of automotive and recreational vehicle
parts)
|
Magog,
Quebec,
Canada
|
May
2000
|
5,000
|
-
|
Guy
Marier (3)
(4)
Independent
Director
|
Executive
Consultant
|
Lakefield
Gore, Quebec,
Canada
|
January
2004
|
1,000
|
-
|
André
Tremblay(3)
(4)
Independent
Director
|
Founder
and Managing Partner,
Trio
Capital Inc. (a private equity fund management company)
|
Outremont,
Quebec,
Canada
|
May
2000
|
6,650(5)
|
-
|
Dr.
David A. Thompson, Ph.D.(4)
Independent
Director
|
Vice-President&
Director, Hardware & Equipment Technology Strategy, Corning Cable
Systems (involved in manufacturing innovative products for the
telecommunications industry) (6)
|
Newton,
North
Carolina,
USA
|
June
2000
|
2,100
|
-
|
Michael
Unger(3)
(4)
Independent
Lead Director
|
Executive
Consultant
|
Richmond
Hill, Ontario,
Canada
|
May
2000
|
-
|
-
|
(1) |
Mr.
Lamonde exercises control over this number of Subordinate Voting
Shares
through G. Lamonde Investissements Financiers inc., a company
controlled by Mr. Lamonde.
|
(2) |
Mr.
Lamonde exercises control over this number of Multiple Voting Shares
through G. Lamonde Investissements Financiers inc., a company
controlled by Mr. Lamonde and through Fiducie Germain Lamonde, a
family
trust for the benefit of Mr. Lamonde’s family.
|
(3) |
Member
of the Audit Committee.
|
(4) |
Member
of the Human Resources Committee.
|
(5) |
Mr.
Tremblay exercises control over this number of Subordinate Voting
Shares
through 9104-5559 Quebec inc. a company controlled by Mr.
Tremblay.
|
(6) |
Corning
Incorporated is a diversified technology company that concentrate
its
efforts on high-impact growth opportunities. Corning combines its
expertise in specialty glass, ceramic materials, polymers and the
manipulation of the properties of light, with strong process and
manufacturing capabilities to develop, engineer and commercialize
significant innovative products for the telecommunications, flat
panel
display, environmental, semiconductor, and life sciences
industries.
|
Annual
Retainer for Directors: (1)
|
CA$50,000
(2)
|
US$43,550
(3)
|
Annual
Retainer for Committee Chairman:
|
CA$5,000
|
US$4,355
(3)
|
Annual
Retainer for Committee Members:
|
CA$3,000
|
US$2,613
(3)
|
Fees
for all Meetings Attended per day in Person:
|
CA$1,000
|
US$871
(3)
|
Fees
for all Meetings Attended per day by Telephone:
|
CA$500
|
US$436
(3)
|
(1) |
All
the Directors elected to receive 50% of their Annual Retainer in
form of
Deferred Share Units.
|
(2) |
The
Annual Retainer for Mr. David A. Thompson is US$50,000
(CA$57,405).
|
(3) |
The
compensation information has been converted from Canadian dollars
to U.S.
dollars based upon an average foreign exchange rate of CA$1.1481
= US$1.00
for 2006.
|
Name
|
Annual
Compensation Paid in Cash (US$) (1)
|
Annual
Compensation Paid in DSUs (#) (2)
|
Estimated
Value of DSUs at the time of grant (US$) (3)
|
Total
Attendance Fees Paid in Cash (US$) (1)
|
Pierre
Marcouiller (4)
|
27,001
|
3,812
|
21,775
|
6,533
|
Guy
Marier (4)
|
27,001
|
3,812
|
21,775
|
6,968
|
Dr.
David A. Thompson (5)
|
27,613
|
4,308
|
25,000
|
3,049
|
André
Tremblay (6)
|
28,743
|
3,812
|
21,775
|
6,097
|
Michael
Unger (7)
|
28,743
|
3,812
|
21,775
|
6,533
|
(1) |
The
compensation information has been converted from Canadian dollars
to U.S.
dollars based upon an average foreign exchange rate of CA$1.1481
= US$1.00
for 2006 except for Mr. David A. Thompson who is paid in U.S. dollar
for
the portion of his annual retainer for Director. The Annual Compensation
includes, as the case may be, the retainer for Director, Committee
Members
and Committee Chairman.
|
(2) |
Indicates
the number of Subordinate Voting Shares granted under the Deferred
Share
Unit Plan. A DSU is converted in a Subordinate Voting Share when
a
Director ceases to be a member of the
Board.
|
(3) |
The
estimated value at the time of grant of a DSU is determined based
on the
highest of the closing prices of the Subordinate Voting Shares on
the
Toronto Stock Exchange and the NASDAQ National Market on the last
trading
day preceding the grant date, using the noon buying rate of the Federal
Reserve Bank of New York on the grant date to convert the NASDAQ
National
Market closing price to Canadian dollars, as required. The value
at
vesting of a DSU is equivalent to the market value of a Subordinate
Voting
Share when a DSU is converted to such Subordinate Voting
Share.
|
(4) |
Member
of the Audit Committee and the Human Resources
Committee.
|
(5) |
Member
of the Human Resources Committee.
|
(6) |
Member
of the Human Resources Committee and Chairman of the Audit
Committee.
|
(7) |
Member
of the Audit Committee, Chairman of the Human Resources Committee
and Lead
Director.
|
Name
and Principal
Position
|
Financial
Years
|
Salary
(1)
($)
|
Bonus
(2)
($)
|
Other
Annual Compensation ($)
|
Securities
Under Options (3)
(#)
|
Restricted
Share Units (4)
(#)
|
All
Other
Compensation
($)
|
Germain
Lamonde,
President
and Chief Executive Officer
|
2006
|
271,753 (US)
312,000 (CA)
|
147,558 (US)
169,412 (CA)
|
-
|
11,218
|
21,477
|
-
|
2005
|
243,605 (US)
300,000 (CA)
|
121,729 (US)
149,909 (CA)
|
-
|
17,942
|
13,089
|
-
|
|
2004
|
206,751 (US)
275,000 (CA)
|
57,115 (US)
75,969 (CA)
|
-
|
-
|
-
|
-
|
Name
and Principal
Position
|
Financial
Years
|
Salary
(1)
($)
|
Bonus
(2)
($)
|
Other
Annual Compensation ($)
|
Securities
Under Options (3)
(#)
|
Restricted
Share Units (4)
(#)
|
All
Other
Compensation
($)
|
Pierre
Plamondon,
Vice-President
Finance and Chief Financial Officer
|
2006
|
165,691 (US)
190,230 (CA)
|
60,167 (US)
69,078 (CA)
|
-
|
3,653
|
6,994
|
4,283 (US)
(5)
4,918 (CA)
|
2005
|
151,441 (US)
186,500 (CA)
|
48,735 (US)
60,017 (CA)
|
-
|
5,383
|
33,927
|
2,316 (US)
(5)
2,852 (CA)
|
|
2004
|
135,328 (US)
180,000 (CA)
|
17,451 (US)
23,211 (CA)
|
-
|
-
|
-
|
1,429 (US)
(5)
1,901 (CA)
|
|
Juan-Felipe
Gonzalez,
Vice-President
Telecom Sales - International
|
2006
|
272,518 (US)
312,878 (CA)
|
12,891 (US)
14,800 (CA)
|
-
|
3,505
|
6,716
|
-
|
2005
|
246,323 (US)
303,347 (CA)
|
6,015 (US)
7,407 (CA)
|
-
|
5,482
|
33,998
|
-
|
|
2004
|
231,597 (US)
308,047 (CA)
|
563,867 (US)
750,000 (CA)
(6)
|
-
|
-
|
-
|
-
|
|
Allan
Firhoj,
Vice-President
and General Manager, Life Sciences and Industrial Division
|
2006
|
139,361 (US)
160,000 (CA)
|
40,632 (US)
46,650 (CA)
|
-
|
2,404
|
4,602
|
-
|
2005
|
123,153 (US)
151,663 (CA)
|
18,355 (US)
22,604 (CA)
|
-
|
2,512
|
12,443
|
-
|
|
2004
|
107,796 (US)
143,379 (CA)
|
18,890 (US)
25,125 (CA)
|
-
|
-
|
-
|
-
|
|
Dana
Yearian,
Vice-President
Telecom Sales - North America
|
2006
|
173,424 (US)
(7)
199,109 (CA)
|
-
-
|
-
|
-
|
5,000
|
236 (US)
(5)
270 (CA)
|
2005
|
-
-
|
-
-
|
-
|
-
|
-
|
-
|
|
2004
|
-
-
|
-
-
|
-
|
-
|
-
|
-
|
(1) |
The
compensation information for Canadian residents has been converted
from
Canadian dollars to U.S. dollars based upon an average foreign exchange
rate of CA$1.1481 = US$1.00 for 2006, CA$1.2315 = US$1.00 for 2005
and
CA$1.3301 = US$1.00 for 2004. The currency conversions cause these
reported salaries to fluctuate from year-to-year because of the
fluctuation in exchange rate.
|
(2) |
A
portion of the bonus amounts is paid in cash in the year for which
they
are awarded and the balance is paid in cash in the year following
the
financial year for which they are
awarded.
|
(3) |
Indicates
the number of Subordinate Voting Shares underlying the options granted
under the Long-Term Incentive Plan during the financial year
indicated.
|
(4) |
Indicates
the number of Restricted Share Units granted under the Long-Term
Incentive
Plan during the financial year
indicated.
|
(5) |
Indicates
the amount contributed by the Corporation during the financial year
indicated to the Deferred Profit Sharing Plan, as applicable, for
the
benefit of the Named Executive Officer. Mr. Lamonde is not eligible
to
participate in the Deferred Profit Sharing Plan and Mr. Gonzalez did
not participate.
|
(6) |
Pursuant
to the terms of his employment agreement, Mr. Juan-Felipe Gonzalez
receive
a cash payment of CA$750,000 because he did not voluntarily resign
and was
not dismissed with cause prior to September 2003. An amount of CA$500,000
was disbursed on October 17 2003 and the remaining CA$250,000
was disbursed on January 25, 2004.
|
(7) |
This
amount represents Mr. Yearian’s annual base salary. Since Mr. Yearian
joined the Corporation on August 14, 2006, the base salary paid to
Mr.
Yearian for the financial year ended August 31, 2006 amounted to
US$7,851
(CA$9,014).
|
DSUs
#
|
Weighted
Average Estimated Value at the
Time
of Grant US$/DSU
|
Vesting
|
19,556
|
5.81
|
At
the time director cease to be a member of the Board of the
Corporation
|
RSUs
#
|
Fair
Value at the Time of Grant US$/RSU
|
Vesting (1)
|
61,253
|
4.76
|
100%
on the fifth anniversary date of the grant in December 2005 subject
to
early vesting up to 1/3 on the third anniversary date of the grant
and up
to 50% of the remaining units on the fourth anniversary date of the
grant
if the performance objectives are fully attained. (2)
|
86,700
|
5.59
|
50%
on the third and fourth anniversary dates of the grant in February
2006.
(3)
|
1,500
|
6.50
|
50%
on the third and fourth anniversary dates of the grant in February
2006.
(3)
|
13,850
|
6.58
|
50%
on the third and fourth anniversary dates of the grant in February
2006.
(3)
|
3,500
|
5.90
|
50%
on the third and fourth anniversary dates of the grant in June 2006.
(4)
|
2,000
|
6.27
|
50%
on the third and fourth anniversary dates of the grant in June 2006.
(4)
|
5,000
|
5.16
|
1/3
on each of the third, fourth and fifth anniversary dates of the grant
in
August 2006 (5)
|
(1)
|
All
RSUs first vesting can not be earlier than the third anniversary
date of
their grant.
|
(2) |
Those
RSUs granted in the financial year ended August 31, 2006 vest on
the fifth
anniversary date of the grant in December 2005 but are subject to
early
vesting on the third and fourth anniversary dates of the grant on
the
attainment of performance objectives as determined by the Board of
Directors of the Corporation. Accordingly, subject to the attainment
of
performance objectives, the first early vesting is up to 1/3 of the
units
on the third anniversary date of the grant and the second early vesting
is
up to 50% of the remaining units on the fourth anniversary date of
the
grant.
|
(3) |
Those
RSUs granted in the financial year ended August 31, 2006 vest at
a rate of
1/2 annually commencing on the third anniversary date of the grant
in
February 2006.
|
(4) |
Those
RSUs granted in the financial year ended August 31, 2006 vest at
a rate of
1/2 annually commencing on the third anniversary date of the grant
in June
2006.
|
(5) |
Those
RSUs granted in the financial year ended August 31, 2006 vest at
a rate of
1/3 annually commencing on the third anniversary date of the grant
in
August 2006.
|
Name
|
RSUs
#
|
Percentage
of Net Total of RSUs Granted to Employees in Financial
Year
(%)
|
Fair
Value at the Time of Grant US$/RSU
|
Vesting
(1)
|
Germain
Lamonde
|
21,477
|
12.36
|
4.76
|
100%
on the fifth anniversary date of the grant in December 2005 subject
to
early vesting up to 1/3 on the third anniversary date of the grant
and up
to 50% of the remaining units on the fourth anniversary date of
the grant
if the performance objectives are fully attained. (2)
|
Pierre
Plamondon
|
6,994
|
4.02
|
4.76
|
100%
on the fifth anniversary date of the grant in December 2005 subject
to
early vesting up to 1/3 on the third anniversary date of the grant
and up
to 50% of the remaining units on the fourth anniversary date of
the grant
if the performance objectives are fully attained. (2)
|
Juan-Felipe
Gonzalez
|
6,716
|
3.86
|
4.76
|
100%
on the fifth anniversary date of the grant in December 2005 subject
to
early vesting up to 1/3 on the third anniversary date of the grant
and up
to 50% of the remaining units on the fourth anniversary date of
the grant
if the performance objectives are fully attained. (2)
|
Allan
Firhoj
|
4,602
|
2.65
|
4.76
|
100%
on the fifth anniversary date of the grant in December 2005 subject
to
early vesting up to 1/3 on the third anniversary date of the grant
and up
to 50% of the remaining units on the fourth anniversary date of
the grant
if the performance objectives are fully attained. (2)
|
Dana
Yearian
|
5,000
|
2.88
|
5.16
|
1/3
on each of third, fourth and fifth anniversary dates of the grant
in
August 2006. (3)
|
(1) |
All
RSUs first vesting can not be earlier than the third anniversary
date of
their grant.
|
(2) |
Those
RSUs granted in the financial year ended August 31, 2006 vest on
the fifth
anniversary date of the grant in December 2005 but are subject to
early
vesting on the third and fourth anniversary date of the grant on
the
attainment of performance objectives as determined by the Board of
Directors of the Corporation. Accordingly, subject to the attainment
of
performance objectives, the first early vesting is up to 1/3 of the
units
on the third anniversary date of the grant and the second early vesting
is
up to 50% of the remaining units on the fourth anniversary date of
the
grant.
|
(3) |
Those
RSUs granted in the financial year ended August 31, 2006 vest at
a rate of
1/3 annually commencing on the third anniversary date of the grant
in
August 2006.
|
Name
|
Securities
Acquired on Vesting (#)
|
Aggregate
Value Realized (US$) (1)
|
Unvested
RSUs
at
August 31, 2006 (#)
|
Value
of Unvested RSUs
at
August 31, 2006 (US$) (2)
(3)
|
Germain
Lamonde
|
-
|
-
|
34,566
|
181,472
|
Pierre
Plamondon
|
-
|
-
|
40,921
|
214,835
|
Juan-Felipe
Gonzalez
|
-
|
-
|
40,714
|
213,749
|
Allan
Firhoj
|
-
|
-
|
17,045
|
89,486
|
Dana
Yearian
|
-
|
-
|
5,000
|
26,250
|
(1) |
The
aggregate value realized is equivalent to the market value of the
securities underlying the RSUs at vesting. This value, as the case
maybe,
has been converted from Canadian dollars to U.S. dollars based upon
the
average foreign exchange rate on the day of
vesting.
|
(2) |
The
value of RSUs is calculated using the highest of the closing prices
of the
Subordinate Voting Shares on the Toronto Stock Exchange and on the
NASDAQ
National Market on August 31, 2006 using the noon buying rate of
the
Federal Reserve Bank of New York to convert the NASDAQ National Market
closing price to Canadian dollars, as
required.
|
(3) |
The
actual gains on vesting will depend on the value of the Subordinate
Voting
Shares on the date of vesting. There can be no assurance that these
values
will be realized.
|
Name
|
Securities
Under Options
Granted(1)
(#)
|
Percentage
of Net Total of Options Granted to Employees in Financial
Year
(%)
|
Exercise
or Base Price (2)
(US$/
Security)
|
Market
Value of Securities Underlying Options on the Date of Grant (US$/Security)
(3)
|
Expiration
Date
|
Germain
Lamonde
|
11,218
|
35.07
|
4.76
(4)
|
4.85
(5)
|
December
6, 2015
|
Pierre
Plamondon
|
3,653
|
11.42
|
4.76
(4)
|
4.85
(5)
|
December
6, 2015
|
Juan-Felipe
Gonzalez
|
3,505
|
10.96
|
4.76
(4)
|
4.85
(5)
|
December
6, 2015
|
Allan
Firhoj
|
2,404
|
7.51
|
4.76
(4)
|
4.85
(5)
|
December
6, 2015
|
Dana
Yearian
|
-
|
-
|
-
|
-
|
-
|
(1)
|
Underlying
securities: Subordinate Voting Shares.
|
(2) |
The
exercise price of options granted is determined based on the highest
of
the closing prices of the Subordinate Voting Shares on the Toronto
Stock
Exchange and the NASDAQ National Market on the last trading day preceding
the grant date, using the noon buying rate of the Federal Reserve
Bank of
New York on the grant date to convert the NASDAQ National Market
closing
price to Canadian dollars, as required. These options vest at a rate
of
25% annually commencing on the first anniversary date of the
grant.
|
(3) |
Based
on the closing price on the NASDAQ National Market on the date of
the
grant.
|
(4) |
Being
CA$5.50.
|
(5) |
Being
CA$5.60.
|
Name
|
Securities
Acquired on Exercise (#)
|
Aggregate
Value Realized (US$) (1)
(4)
|
Unexercised
Options
at
August 31, 2006
|
Value
of Unexercised
“In-the-Money”
Options at
August
31, 2006 (2)
(3) (4)
|
||
Exercisable
(#)
|
Unexercisable
(#)
|
Exercisable
(US$)
|
Unexercisable
(US$)
|
|||
Germain
Lamonde
|
-
|
-
|
142,468
|
37,174
|
114,157
|
44,093
|
Pierre
Plamondon
|
5,000
|
31,497
|
67,035
|
13,941
|
41,501
|
19,986
|
Juan-Felipe
Gonzalez
|
7,500
|
47,246
|
83,900
|
15,117
|
-
|
23,714
|
Allan
Firhoj
|
8,337
|
47,058
|
18,000
|
8,666
|
-
|
12,057
|
Dana
Yearian
|
-
|
-
|
-
|
-
|
-
|
-
|
(1) |
The
aggregate value realized is equivalent to the difference between
the
market value of the securities underlying the options at exercise
and the
exercise price of the options. This value, as the case maybe, has
been
converted from Canadian dollars to U.S. Dollars based upon the average
foreign exchange rate on the day of the
exercise.
|
(2) |
“In-the-money”
options are options for which the market value of the underlying
securities is higher than the price at which such securities may
be bought
from the Corporation.
|
(3) |
The
value of unexercisable “in-the-money” options is calculated using the
highest of the closing prices of the Subordinate Voting Shares on
the
Toronto Stock Exchange and on the NASDAQ National Market on August
31,
2006 using the noon buying rate of the Federal Reserve Bank of New
York to
convert the NASDAQ National Market closing price to Canadian dollars,
as
required, less the exercise price of “in-the-money”
options.
|
(4) |
This
value has been converted from Canadian to US dollars based upon the
foreign exchange rate on August 31, 2006 of
1.1066.
|
· |
Performance-based:
Executive compensation levels reflect both corporation and individual
results based on specific quantitative and qualitative objectives
established at the start of each financial year in keeping with
Corporation’s long-term strategic objectives.
|
· |
Aligned
with shareholder interests:
A
significant proportion of incentive compensation for executives is
composed of equity awards to ensure that executives are aligned with
the
principles of sustained long-term shareholder value
growth.
|
· |
Market
competitive:
Compensation of executives is designed to be externally competitive
when
compared against executives of comparable peer companies, and in
consideration of Corporation results relative to the results of
peers.
|
· |
Individually
equitable:
Compensation levels are also designed to reflect individual factors
such
as scope of responsibility, experience, and performance against individual
measures.
|
Measure
|
Weighting
Mr. Lamonde and Mr. Plamondon
|
Weighting
Mr. Firhoj
|
Sales
|
35%
|
30%
|
Earnings
|
15%
|
25%
|
Gross
margin
|
25%
|
25%
|
Customer
satisfaction (quality and on time delivery)
|
25%
|
20%
|
Personal
objectives (multiplier)
|
0%
- 125%
|
0%
- 125%
|
Number
of Options
|
%
of Issued and
Outstanding
Options
|
Weighted
Average Exercise Price ($US/Security)
|
|
President
and CEO (one individual)
|
179,642
|
7.36%
|
9.05
|
Board
of Directors (five individuals)
|
194,375
|
7.97%
|
6.23
|
Management
and Corporate Officers (eight individuals)
|
313,836
|
12.87%
|
15.42
|
Number
of RSUs
|
%
of Issued and
Outstanding
RSUs
|
Weighted
Average Fair Value at the Time of Grant
$US/RSU
|
|
President
and CEO (one individual)
|
34,566
|
10.54%
|
4.73
|
Board
of Directors (five individuals)
|
-
|
-
|
-
|
Management
and Corporate Officers (ten individuals)
|
184,161
|
56,17%
|
4.66
|
Measure
|
Weighting
ALL
|
Sales
|
35%
|
Earnings
|
15%
|
Gross
margin
|
25%
|
Customer
satisfaction (quality and on time delivery)
|
25%
|
Personal
objectives (multiplier)
|
0%
- 125%
|
Number
of DSUs
|
%
of Issued and
Outstanding
DSUs
|
Weighted
Average Estimated Value at the Time of Grant
$US/DSU
|
|
Board
of Directors (five individuals)
|
43,290
|
100%
|
5.07
|
(a) |
one
copy of the Annual Report on Form 20-F of the Corporation filed with
the
Securities and Exchange Commission (the “SEC”) in the United States
pursuant to the Securities
Exchange Act of 1934,
and with securities commissions or similar
authorities;
|
(b) |
one
copy of the comparative consolidated financial statements of the
Corporation for its most recently completed financial year and the
Auditors report thereon, included in the Annual Report of the Corporation
and one copy of any interim consolidated financial statements of
the
Corporation subsequent to the consolidated financial statements for
its
most recently completed financial
year;
|
(c) |
one
copy of this Management Proxy
Circular.
|
CSA
Guidelines
|
EXFO
Electro-Optical Engineering’s Corporate Governance
Practices
|
1. Board
of Directors
|
|
(a) Disclose
the identity of directors who are independent.
|
The
following directors are independent:
Mr.
Pierre Marcouiller
Mr.
Guy Marier
Mr.
André Tremblay
Dr.
David A. Thompson
Mr.
Michael Unger
|
(b) Disclose
the identity of directors who are not independent, and describe
the basis
for that determination.
|
Mr.
Germain Lamonde - non-independent - is President and Chief Executive
Officer of the Corporation and a significant shareholder of the
Corporation as he has the ability to exercise a majority of the
votes for
the election of the Board of Directors.
|
(c) Disclose
whether or not a majority of directors are independent. If a majority
of
directors are not independent, describe what the board of directors
does
to facilitate its exercise of independent judgement in carrying
out its
responsibilities.
|
The
majority of directors are independent.
|
(d) If
a director is presently a director of any other issuer that is
a reporting
issuer (or the equivalent) in a jurisdiction or a foreign jurisdiction,
identify both the director and the other issuer.
|
Michael
Unger is a director of Tundra Semiconductor Corporation, a public
corporation of Ottawa. Guy Marier is a Director of Bell Nordic
Income
Fund. Pierre Marcouiller is a Director of Héroux-Devtek
Inc.
|
(e) Disclose
whether or not the independent directors hold regularly scheduled
meetings
at which non-independent directors and members of management are
not in
attendance. If the independent directors hold such meetings, disclose
the
number of meetings held since the beginning of the issuer’s most recently
completed financial year. If the independent directors do not hold
such
meetings, describe what the board does to facilitate open and candid
discussion among its independent directors.
|
The
independent Directors hold as many meeting, as needed, annually
and any
Director may request such meeting at any time. Since September
1, 2005 and
prior to November 1, 2006, three (3) meetings of independent Directors
without management occurred.
|
(f) Disclose
whether or not the chair of the board is an independent director.
If the
board has a chair or lead director who is an independent director,
disclose the identity of the independent chair or lead director,
and
describe his or her role and responsibilities. If the board has
neither a
chair that is independent nor a lead director that is independent,
describe what the board does to provide leadership for its independent
directors.
|
The
Chair of the Board is not an independent director. During the financial
year ended August 31, 2002, the Board of Directors designated Mr.
Michael
Unger to act as the independent “Lead Director”.
The
Lead Director is an outside and unrelated director appointed by
the Board
of Directors to ensure that the Board can perform its duties in
an
effective and efficient manner independent of management. The appointment
of a Lead Director is part of EXFO’s ongoing commitment to good corporate
governance. The Lead Director will namely:
· provide
independent leadership to the Board;
· facilitate
the functioning of the Board independently of the Corporation’s
management;
· maintain
and enhance the quality of the Corporation’s corporate governance
practices.
· in
the absence of the Executive Chair, act as chair of meetings of
the
Board;
· recommend,
where necessary, the holding of special meetings of the
Board;
· serve
as Board ombudsman, so as to ensure that questions or comments
of
individual directors are heard and addressed;
· manage
and investigate any report received through the Corporation website
pursuant to the Corporation’s Statement on reporting Ethical Violations
and Ethics and Business Conduct Policy;
· work
with the Board of Directors to facilitate the process for developing,
monitoring and evaluating specific annual objectives for the Board
each
year.
|
||||||
(g) Disclose
the attendance record of each director for all board meetings held
since
the beginning of the issuer’s most recently completed financial
year.
|
The
table below indicates the directors’ record of attendance at meetings of
the Board of Directors and its committees during the financial
year ended
August 31, 2006:
|
||||||
Director
|
Board
meetings
attended
|
Audit
Committee
meetings
attended
|
Human
Resources Committee meetings attended
|
Independent
Directors meetings attended
|
Total
Board and
Committee
meetings
attendance
rate
|
||
Lamonde,
Germain
|
7
of 7
|
n/a
|
n/a
|
n/a
|
100%
|
||
Marcouiller,
Pierre
|
7
of 7
|
5
of 5
|
5
of 5
|
3
of 4
|
95%
|
||
Marier,
Guy
|
7
of 7
|
5
of 5
|
5
of 5
|
4
of 4
|
100%
|
||
Thompson,
David
|
4
of 7
|
n/a
|
2
of 5
|
1
of 4
|
44%
|
||
Tremblay,
André
|
6
of 7
|
5
of 5
|
4
of 5
|
4
of 4
|
90%
|
||
Unger,
Michael
|
7
of 7
|
4
of 5
|
5
of 5
|
4
of 4
|
95%
|
||
Attendance
Rate:
|
90%
|
95%
|
84%
|
80%
|
88%
|
2. Board
Mandate -
Disclose the text of the board’s written mandate. If the board does not
have a written mandate, describe how the board delineates its role
and
responsibilities.
|
|
(a) Assuring
the integrity of the executive officers and creating a culture
of
integrity throughout the organisation.
|
The
Board is committed to maintaining the highest standards of integrity
throughout the organisation. Accordingly, the Board adopted an
Ethics and
Business Conduct Policy and a Statement on Reporting Ethical Violations
(“Whistleblower Policy”) which are available on EXFO website at www.
EXFO.com to all employees and formerly distributed to every new
employees
of the Corporation.
|
(b) Adoption
of a strategic planning process
|
The
Board provides guidance for the development of the strategic planning
process and approves the process and the plan developed by management
annually. In addition, the Board carefully reviews the strategic
plan and
deals with strategic planning matters that arise during the
year.
|
(c) Identification
of principal risks and implementing of risk management
systems
|
The
Board works with management to identify the Corporation’s principal risks
and manages these risks through regular appraisal of management’s
practices on an ongoing basis.
|
(d) Succession
planning including appointing, training and monitoring senior
management
|
The
Human Resources Committee is responsible for the elaboration and
implementation of a succession planning process and its updates
as
required. The Human Resources Committee is responsible to monitor
and
review the performance of the Chief Executive Officer and that
of all
other senior officers.
|
(e) Communications
policy
|
The
Chief Financial Officer of the Corporation is responsible for
communications between Management and the Corporation’s current and
potential shareholders and financial analysts. The Board adopted
and
implemented Disclosure Guidelines to ensure consistency in the
manner that
communications with shareholders and the public are managed. The
Audit
Committee reviews press releases containing the quarterly results
of the
Corporation prior to release. In addition, all material press releases
of
the Corporation are reviewed by the President and Chief Executive
Officer,
Chief Financial Officer, Investor Relations Manager, Manager of
Financial
Reporting and Accounting and Internal Legal Counsel. The Disclosure
Guidelines have been established in accordance with the relevant
disclosure requirements under applicable Canadian and United States
securities laws.
|
(f) Integrity
of internal control and management information systems
|
The
Audit Committee has the responsibility to review the Corporation’s systems
of internal controls regarding finance, accounting, legal compliance
and
ethical behaviour. The Audit Committee meets with the Corporation’s
external auditors on a quarterly basis. Accordingly, the Corporation
fully
complies with Sarbanes-Oxley Act requirements within the required
period
of time.
|
(g) Approach
to corporate governance including developing a set of corporate
governance
principles and guidelines that are specifically applicable to the
issuer
|
The
Board assumes direct responsibility for the monitoring of the Board’s
corporate governance practices, the functioning of the Board and
the
powers, mandates and performance of the committees. These responsibilities
were previously assumed by the Human Resources Committee. Accordingly,
the
Board updated and adopted in March 2005 the following policies
to fully
comply with these responsibilities:
· Audit
Committee Charter*;
· Board
of Directors Corporate Governance Guidelines*;
· Code
of Ethics for our Principal Executive Officer and Senior Financial
Officers*;
· Disclosure
Guidelines;
· Ethics
and Business Conduct Policy*;
· Human
Resources Committee Charter*;
· Securities
Trading Policy;
· Statement
on Reporting Ethical Violations (Whistle Blower)*.
The
Board also adopted in October 2006 the Policy Regarding Hiring
Employees
and Former Employees of Independent Auditors which is also available
on
EXFO website at www.EXFO.com.
*
available on EXFO website at www.EXFO.com.
|
(h) Expectations
and responsibilities of Directors, including basic duties and
responsibilities with respect to attendance at board meetings and
advance
review of meeting materials
|
The
Board is also responsible for the establishment and functioning
of all
Board committees, their compensation and their good standing. At
regularly
scheduled meetings of the Board, the Directors receive, consider
and
discuss committee reports. The Directors also receive in advance
of any
meeting, all documentation required for the upcoming meetings and
they are
expected to review and consult this
documentation.
|
3. Position
Descriptions
|
|
(a) Disclose
whether or not the board has developed written position descriptions
for
the chair of the board and the chair of each board committee. If
the board
has not developed written position descriptions for the chair and/or
the
chair of each board committee, briefly describe how the board delineates
the role and responsibilities of each such position.
|
There
is no specific mandate for the Board, however the Board of Directors
is,
by law, responsible for managing the business and affairs of the
Corporation. Any responsibility which is not delegated to senior
management or to a committee of the Board remains the responsibility
of
the Board. Accordingly, the chair of the Board, of the Audit Committee
and
of the Human Resources Committee will namely:
· provide
leadership to the Board or Committee;
· ensure
that the Board or Committee can perform its duties in an effective
and
efficient manner;
· facilitate
the functionary of the Board or Committee;
· promote
best practices and high standards of corporate governance.
|
(b) Disclose
whether or not the board and CEO have developed a written position
description for the CEO. If the board and CEO have not developed
such a
position description, briefly describe how the board delineates
the role
and responsibilities of the CEO.
|
No
written position description has been developed for the CEO. The
President
and Chief Executive Officer, along with the rest of management
placed
under his supervision, is responsible for meeting the corporate
objectives
as determined by the strategic objectives and budget as they are
adopted
each year by the Board of Directors.
|
4. Orientation
and Continuing Education
|
|
(a) Briefly
describe what measures the board takes to orient new directors
regarding
(i) the
role of the board, its committees and its directors, and
(ii) the
nature and operation of the issuer’s business.
|
The
Human Resources Committee Charter foresees that the Human Resource
Committee maintain an orientation program for New Directors.
Presentations
and reports relating to the Corporation’s business and affairs are
provided to new Directors. In addition, new Board members meet
with senior
management of the Corporation to review the business and affairs
of the
Corporation.
|
(b) Briefly
describe what measures, if any, the board takes to provide continuing
education for its directors. If the board does not provide continuing
education, describe how the board ensures that its directors maintain
the
skill and knowledge necessary to meet their obligations as
directors.
|
The
Human Resources Committee Charter foresees that the Human Resources
Committee maintains a continuing education programs for
Directors.
|
5. Ethical
Business Conduct
|
|
(a) Disclose
whether or not the board has adopted a written code for the directors,
officers and employees. If the board has adopted a written
code:
i. disclose
how a person or company may obtain a copy of the code;
ii. describe
how the board monitors compliance with its code, or if the board
does not
monitor compliance, explain whether and how the board satisfies
itself
regarding compliance with its code; and
iii. provide
a cross-reference to any material change report filed since the
beginning
of the issuer’s most recently completed financial year that pertains to
any conduct of a director or executive officer that constitutes
a
departure from the code.
|
The
Corporation is committed to maintaining the highest standard of
business
conduct and ethics. Accordingly, the Board updated and established
(i) a
Board of Directors Corporate Governance Guidelines (ii) a Code
of Ethics
for our Principal Executive Officer and senior Financial Officers
(iii)
Ethics and Business Conduct Policy and (iv) a Statement on Reporting
Ethical Violations “Whistleblower Policy” which are available on the
Corporation’s website at www.EXFO.com.
The
Board of Directors will determine, or designate appropriate persons
to
determine, appropriate actions to be taken in the event of a violation
of
the Code of Ethics for our Principal Executive Officer and senior
Financial Officers. Someone that does not comply with this Code
of Ethics
will be subject to disciplinary measures, up to and including discharge
from the Corporation. Furthermore, a compliance affirmation must
be filled
in a written form agreeing to abide by the policies of the Code
of
Ethics.
No
material change report has been required or filed during our financial
year ended August 31, 2006 with respect to any conduct constituting
a
departure from our Code of Ethics.
|
(b) Describe
any steps the board takes to ensure directors a material
interest,
exercise independent judgement in considering transactions and
agreements
in respect of which a director or executive officer has a material
interest.
|
Activities
that could give rise to conflicts of interest are prohibited. Board
members should contact the Lead Director or in-house legal counsel
regarding any issues relating to possible conflict of interest.
If such
event occurs, the implicated Board member will not participate
in the
meeting and discussion with respect to such possible conflict of
interest
and will not be entitled to vote on such matter. Senior executives
should
also contact the in-house legal counsel regarding any issues relating
to
possible conflict of interest.
|
(c) Describe
any other steps the board takes to encourage and promote a culture
of
ethical business conduct.
|
The
Corporation has instituted and follows a “Whistleblower Policy” where each
member of the Board as well as any senior officer, every employee
of the
Corporation and any person is invited and encouraged to report
anything
appearing or suspected of being non-ethical to our Lead Director,
in
confidence. The Lead Director has the power to hire professional
assistance to conduct an internal investigation should he so fell
required.
|
6. Nomination
of Directors
|
|
(a) Describe
the process by which the board identifies new candidates for board
nomination.
|
The
Board adopted and implemented a Human Resources Committee Charter
which
integrates the Compensation Committee Charter and the Nominating
and
Governance Committee Charter. The Human Resources Committee is
responsible
for nomination, assessment and compensation of directors and
Officers.
|
(b) Disclose
whether or not the board has a nominating committee composed entirely
of
independent directors. If the board does not have a nominating
committee
composed entirely of independent directors, describe what steps
the board
takes to encourage an objective nomination process.
|
The
Human Resources Committee consists of five members all of who are
independent Directors. The Chairman of the Human Resources Committee
is
Mr. Michael Unger.
The
Human Resources Committee Charter namely foresees:
· The
Committee to identify individuals qualified to become members of
the
Board, to conduct background checks respecting such individuals,
to
recommend that the Board select the director nominees for the next
annual
meeting of shareholders;
|
(c) If
the board has a nominating committee, describe the responsibili-ties,
powers and operation of the nominating committee.
|
|
7. Compensation
|
|
(a) Describe
the process by which the board determines the compensation for
the
issuer’s directors and officers.
|
The
Human Resources Committee reviews periodically compensation policies
in
light of market conditions, industry practice and level of
responsibilities. Only independent Directors are compensated for
acting as
a Director of the Corporation.
|
(b) Disclose
whether or not the board has a compensation committee composed
entirely of
independent directors. If the board does not have a compensation
committee
composed entirely of independent directors, describe what steps
the board
takes to ensure an objective process for determining such
compensation.
|
The
Human Resources Committee consists of five members all of who are
independent Directors. The Chairman of the Human Resources Committee
is
Mr. Michael Unger.
|
(c) If
the board has a compensation committee, describe the responsibili-ties,
powers and operation of the compensation committee.
|
The
Human Resources Committee Charter namely foresees:
· The
Committee to review and approve on an annual basis with respect
to the
annual compensation of all senior officers;
· The
Committee to review and approve, on behalf of the Board of Directors
(“the
Board”) or in collaboration with the Board as applicable, on the basis
of
the attribution authorized by the Board, to whom options to purchase
shares of the Corporation, RSUs or DSUs shall be offered as the
case may
be and if so, the terms of such options, RSUs or DSUs in accordance
with
the terms of the Corporation’s Long-Term Incentive Plan or the Deferred
Share Unit Plan provided that no options, RSUs or DSUs shall be
granted to
members of this committee without the approval of the Board;
· The
committee to recommend to the Board from time to time the remuneration
to
be paid by the Corporation to Directors;
· The
Committee to make recommendations to the Board with respect to
the
Corporation’s incentive compensation plans and equity-based
plans.
|
(d) If
a compensation consultant or advisor has, at any time since the
beginning
of the issuer’s most recently completed financial year, been retained to
assist in determining compensation for any of the issuer’s directors and
officers, disclose the identity of the consultant or advisor and
briefly
summarize the mandate for which they have been retained. If the
consultant
or advisor has been retained to perform any other work for the
issuer,
state that fact and briefly describe the nature of the work.
|
In
2004, the Corporation hired Mercer Human Resource Consulting to
conduct a
full market benchmarking and review of the Corporation’s executive
compensation plans. In 2006, Mercer provided data regarding market
competitive annual base salary increases, which were applied to
the
executive compensation structure developed in 2004. In addition,
Mercer
completed mandates on the following topics in 2006:
· Job
classification structure & salary scales (Define Job positions vs
comparable market including salary scale);
· Development
of compensation management policies & practices (to manage employee
progression through the salary scale).
|
8. Other
Board Committees -
If the board has standing committees other than the audit, compensation
and nominating committees, identify the committees and describe
their
function.
|
The
Board has no other standing
committee.
|
9. Assessments -
Disclose whether or not the board, its committees and individual
directors
are regularly assessed with respect to their effectiveness and
contribution. If assessments are regularly conducted, describe
the process
used for the assessments. If assessments are not regularly conducted,
describe how the board satisfies itself that the board, its committees,
and its individual directors are performing effectively.
|
The
Board assumes direct responsibility for the monitoring of the Board’s
corporate governance practices, the functioning of the Board and
the
powers, mandates and performance of the Committee. The Human Resources
Committee, composed solely of independent Directors, initiates
a
self-evaluation of the Board’s performance on an annual
basis.
|